entity|importance|category|chunk_id|type
Mental Health|5|concept|83d4d0367bb0467e811782a4ada3bbb9|concept
Health Equity|4|concept|83d4d0367bb0467e811782a4ada3bbb9|concept
World Health Organization (WHO)|3|organisation|83d4d0367bb0467e811782a4ada3bbb9|concept
United Nations (UN)|3|organisation|83d4d0367bb0467e811782a4ada3bbb9|concept
Sustainable Development Goals (SDGs)|4|document|83d4d0367bb0467e811782a4ada3bbb9|concept
Accelerating Global Health|5|event|1d5cc8cbbb074190b824e1fbc0d644aa|concept
Pathways to Health Equity for the G20|5|event|1d5cc8cbbb074190b824e1fbc0d644aa|concept
Integrating Mental Health into General Healthcare|5|event|1d5cc8cbbb074190b824e1fbc0d644aa|concept
Poverty|4|condition|1d5cc8cbbb074190b824e1fbc0d644aa|concept
Mental Health|5|concept|1d5cc8cbbb074190b824e1fbc0d644aa|concept
Biological Determinants|4|condition|1d5cc8cbbb074190b824e1fbc0d644aa|concept
Psychological Determinants|4|concept|1d5cc8cbbb074190b824e1fbc0d644aa|concept
Social Determinants|4|condition|1d5cc8cbbb074190b824e1fbc0d644aa|concept
Depression|3|concept|1d5cc8cbbb074190b824e1fbc0d644aa|concept
Substance Use Disorders|3|concept|1d5cc8cbbb074190b824e1fbc0d644aa|concept
Behavioural Addictions|3|concept|1d5cc8cbbb074190b824e1fbc0d644aa|concept
Severe Mental Illness (SMI)|3|condition|1d5cc8cbbb074190b824e1fbc0d644aa|concept
Schizophrenia|2|concept|1d5cc8cbbb074190b824e1fbc0d644aa|concept
Bipolar Mood Disorder|2|concept|1d5cc8cbbb074190b824e1fbc0d644aa|concept
adversity|4|condition|1f02a81a02054efaacb0ace0c5eadd14|concept
diabetes|3|condition|1f02a81a02054efaacb0ace0c5eadd14|concept
tuberculosis|3|condition|1f02a81a02054efaacb0ace0c5eadd14|concept
socioeconomic vulnerability|4|condition|1f02a81a02054efaacb0ace0c5eadd14|concept
multimorbidity|3|condition|1f02a81a02054efaacb0ace0c5eadd14|concept
syndemic|4|concept|1f02a81a02054efaacb0ace0c5eadd14|concept
mental health|3|condition|1f02a81a02054efaacb0ace0c5eadd14|concept
healthcare service delivery|5|event|33e4526e998e4865bd5b0dde036c2a20|concept
healthcare resources|4|object|33e4526e998e4865bd5b0dde036c2a20|concept
disadvantaged populations|3|organisation|33e4526e998e4865bd5b0dde036c2a20|concept
mental illness|4|concept|33e4526e998e4865bd5b0dde036c2a20|concept
World Health Organization (WHO)|4|organisation|33e4526e998e4865bd5b0dde036c2a20|concept
Mental Health as a Pathway to Health Equity|5|concept|b9359fe26659413da22ea47729356210|concept
Investing in mental health|4|event|b9359fe26659413da22ea47729356210|concept
Improving population health|3|concept|b9359fe26659413da22ea47729356210|concept
Social inequality|3|condition|b9359fe26659413da22ea47729356210|concept
Human rights|2|concept|b9359fe26659413da22ea47729356210|concept
Economic efficiency|3|concept|b9359fe26659413da22ea47729356210|concept
Global economic loss due to mental disorders|2|misc|b9359fe26659413da22ea47729356210|concept
Investment in treatment of mental illness|3|event|b9359fe26659413da22ea47729356210|concept
Economic productivity gains|2|concept|b9359fe26659413da22ea47729356210|concept
The Burden of Mental Health, Substance Use Disorders and Multimorbidity|3|event|b9359fe26659413da22ea47729356210|concept
Mental and substance-abuse disorders|2|misc|b9359fe26659413da22ea47729356210|concept
Premature morbidity and mortality globally|1|condition|b9359fe26659413da22ea47729356210|concept
National Mental Health Survey (NMHS), 2015-16|1|document|b9359fe26659413da22ea47729356210|concept
India|2|place|b9359fe26659413da22ea47729356210|concept
Disability-Adjusted-Life-Years (DALYs)|5|condition|acf42504124f4b29b4f551d0365821b0|concept
mental disorders|4|concept|acf42504124f4b29b4f551d0365821b0|concept
treatment gap for mental and substance abuse disorders|3|condition|acf42504124f4b29b4f551d0365821b0|concept
out-of-pocket (OOP) spending|2|concept|acf42504124f4b29b4f551d0365821b0|concept
medicines|3|object|acf42504124f4b29b4f551d0365821b0|concept
spending|3|event|5b6399f5e510497481764cd1009caa5c|concept
doctors’ fees and diagnostic charges in OOP expenditure|4|object|5b6399f5e510497481764cd1009caa5c|concept
private healthcare settings|3|place|5b6399f5e510497481764cd1009caa5c|concept
discrimination in the coverage by health insurance toward mental illness|4|misc|5b6399f5e510497481764cd1009caa5c|concept
chances of catastrophic spending|3|event|5b6399f5e510497481764cd1009caa5c|concept
Insurance Regulatory and Development Authority of India (IRDAI)|2|organisation|5b6399f5e510497481764cd1009caa5c|concept
mental illnesses|3|misc|5b6399f5e510497481764cd1009caa5c|concept
Accelerating Global Health|5|event|b123ca85f1a04a5294b943d121e5c61b|concept
Pathways to Health Equity for the G20|4|event|b123ca85f1a04a5294b943d121e5c61b|concept
Mental Health Care Act, 2017|3|document|b123ca85f1a04a5294b943d121e5c61b|concept
reported violations|2|event|b123ca85f1a04a5294b943d121e5c61b|concept
rejections of claims for mental illness by insurance companies|3|event|b123ca85f1a04a5294b943d121e5c61b|concept
discriminatory ceilings on the sum of reimbursement for mental illness|2|event|b123ca85f1a04a5294b943d121e5c61b|concept
people with serious mental illness (SMI)|3|concept|b123ca85f1a04a5294b943d121e5c61b|concept
shortened life expectancy|2|concept|b123ca85f1a04a5294b943d121e5c61b|concept
multimorbidity|3|concept|b123ca85f1a04a5294b943d121e5c61b|concept
non-communicable diseases (NCDs)|2|concept|b123ca85f1a04a5294b943d121e5c61b|concept
tobacco and alcohol use|2|concept|b123ca85f1a04a5294b943d121e5c61b|concept
physical inactivity|2|concept|b123ca85f1a04a5294b943d121e5c61b|concept
poor diets|2|concept|b123ca85f1a04a5294b943d121e5c61b|concept
national programs to address chronic conditions|3|event|b123ca85f1a04a5294b943d121e5c61b|concept
chronic conditions|2|concept|b123ca85f1a04a5294b943d121e5c61b|concept
poor horizontal integration across the programmes|3|event|b123ca85f1a04a5294b943d121e5c61b|concept
homeless persons|2|concept|b123ca85f1a04a5294b943d121e5c61b|concept
women|2|concept|b123ca85f1a04a5294b943d121e5c61b|concept
persons with developmental disorders|2|concept|b123ca85f1a04a5294b943d121e5c61b|concept
mental health equity|5|concept|0fd5e7c372a842cc9368e25bf0cb57b4|concept
social inequality|4|concept|0fd5e7c372a842cc9368e25bf0cb57b4|concept
gender issues|4|concept|0fd5e7c372a842cc9368e25bf0cb57b4|concept
community participation|3|concept|0fd5e7c372a842cc9368e25bf0cb57b4|concept
National Program for Mental Health (NMHP)|5|organisation|0fd5e7c372a842cc9368e25bf0cb57b4|concept
District Mental Health Program (DMHP)|4|organisation|0fd5e7c372a842cc9368e25bf0cb57b4|concept
India|5|place|0fd5e7c372a842cc9368e25bf0cb57b4|concept
Asian countries|3|organisation|0fd5e7c372a842cc9368e25bf0cb57b4|concept
National Mental Health Programme – District Mental Health Programme (>700 districts)|4|document|0fd5e7c372a842cc9368e25bf0cb57b4|concept
Ayushman Bharat-Pradhan Mantri Jan Arogya Yojna (PM-JAY)|5|programme|d1159f0aacce4add93913834766d4b45|concept
Universal Health Coverage|4|concept|d1159f0aacce4add93913834766d4b45|concept
Health and Wellness Centres|4|programme|d1159f0aacce4add93913834766d4b45|concept
National Tele Mental Health Programme (Tele MANAS)|3|programme|d1159f0aacce4add93913834766d4b45|concept
Jan Aushadhi Kendras|4|programme|d1159f0aacce4add93913834766d4b45|concept
National Mental Health Policy (2014)|3|policy|d1159f0aacce4add93913834766d4b45|concept
National Health Policy (2017)|3|policy|d1159f0aacce4add93913834766d4b45|concept
Rights of Persons with Disability Act, 2016|4|legislation|d1159f0aacce4add93913834766d4b45|concept
Mental Health Care Act, 2017|3|legislation|d1159f0aacce4add93913834766d4b45|concept
Accelerating Global Health|5|event|0e19e6305c0049768cd3d005956a6c24|concept
Pathways to Health Equity for the G20|5|event|0e19e6305c0049768cd3d005956a6c24|concept
Psychotropic medications|3|object|0e19e6305c0049768cd3d005956a6c24|concept
Mental Health Policy (2014)|4|document|0e19e6305c0049768cd3d005956a6c24|concept
digital academies at NIMHANS|3|organization|0e19e6305c0049768cd3d005956a6c24|concept
m-Cessation|2|object|0e19e6305c0049768cd3d005956a6c24|concept
tobacco quit-lines|2|organization|0e19e6305c0049768cd3d005956a6c24|concept
National Tele Mental Health Program (Tele Mental Health Assistance and Networking Across States: Tele-MANAS)|4|event|0e19e6305c0049768cd3d005956a6c24|concept
Tele-MANAS initiative|5|organisation|3fc32cb84c4d4da6b29abc6c19d6eb76|concept
World Mental Health Day|3|event|3fc32cb84c4d4da6b29abc6c19d6eb76|concept
tele-mental health services|4|service|3fc32cb84c4d4da6b29abc6c19d6eb76|concept
remote and underserved areas|3|location|3fc32cb84c4d4da6b29abc6c19d6eb76|concept
Box 2. Technological Initiatives in India for Mental Health|4|document|3fc32cb84c4d4da6b29abc6c19d6eb76|concept
Telephone/mobile based initiatives|3|service|3fc32cb84c4d4da6b29abc6c19d6eb76|concept
eSanjeevani|4|organisation|3fc32cb84c4d4da6b29abc6c19d6eb76|concept
e-Manas Karnataka|3|document|3fc32cb84c4d4da6b29abc6c19d6eb76|concept
NIMHANS digital academy|4|organisation|14b35b1d32d540e9b9815a325f95911e|concept
Telemedicine Centre|3|place|14b35b1d32d540e9b9815a325f95911e|concept
NIMHANS|4|organisation|14b35b1d32d540e9b9815a325f95911e|concept
CIP|2|misc|14b35b1d32d540e9b9815a325f95911e|concept
Digital Academy|3|organisation|14b35b1d32d540e9b9815a325f95911e|concept
LGBRIMH Digital Academy|2|misc|14b35b1d32d540e9b9815a325f95911e|concept
NIMHANS ECHO model|3|concept|14b35b1d32d540e9b9815a325f95911e|concept
PGIMER “Tele-enabling model”|3|concept|14b35b1d32d540e9b9815a325f95911e|concept
Chatbots|2|technology|14b35b1d32d540e9b9815a325f95911e|concept
Telerehabilitation|2|technology|14b35b1d32d540e9b9815a325f95911e|concept
Self-help|2|technology|14b35b1d32d540e9b9815a325f95911e|concept
Ayushman Bharat- Pradhan Mantri Jan Arogya Yojna (PM-JAY)|5|organisation|5bbe6986777c47ee854e432f79982bc2|concept
Universal Health Care (UHC) in India|4|concept|5bbe6986777c47ee854e432f79982bc2|concept
Secondary and tertiary hospitalisations|3|event|5bbe6986777c47ee854e432f79982bc2|concept
Annual coverage of INR 500,000 per family|2|document|5bbe6986777c47ee854e432f79982bc2|concept
Generic medicines|3|object|5bbe6986777c47ee854e432f79982bc2|concept
Jan Aushadhi Kendras|2|place|5bbe6986777c47ee854e432f79982bc2|concept
Economic burden|3|concept|5bbe6986777c47ee854e432f79982bc2|concept
Poor and marginalised|2|condition|5bbe6986777c47ee854e432f79982bc2|concept
150,000 Health and Wellness Centres (HWC)|3|organisation|5bbe6986777c47ee854e432f79982bc2|concept
Comprehensive services|2|event|5bbe6986777c47ee854e432f79982bc2|concept
Screening and essential mental health|2|event|5bbe6986777c47ee854e432f79982bc2|concept
mental health services|5|concept|2e92547f635f4574ad69394da1fa736d|concept
general health services|3|concept|2e92547f635f4574ad69394da1fa736d|concept
MHCA 2017|4|document|2e92547f635f4574ad69394da1fa736d|concept
parity for mental illness|3|concept|2e92547f635f4574ad69394da1fa736d|concept
physical conditions|3|concept|2e92547f635f4574ad69394da1fa736d|concept
Central and State Mental Health Authorities|4|organisation|2e92547f635f4574ad69394da1fa736d|concept
Mental Health Review Boards|3|organisation|2e92547f635f4574ad69394da1fa736d|concept
persons with mental illness|4|concept|2e92547f635f4574ad69394da1fa736d|concept
family members|3|concept|2e92547f635f4574ad69394da1fa736d|concept
NGOs|4|organisation|2e92547f635f4574ad69394da1fa736d|concept
checks and balances|3|concept|2e92547f635f4574ad69394da1fa736d|concept
delivery of mental healthcare|4|concept|2e92547f635f4574ad69394da1fa736d|concept
mental illness|5|concept|2e92547f635f4574ad69394da1fa736d|concept
health insurance|4|document|2e92547f635f4574ad69394da1fa736d|concept
Accelerating Global Health|5|event|4cd87763e8f84bdc8f0067b2b4dec451|concept
Pathways to Health Equity for the G20|5|event|4cd87763e8f84bdc8f0067b2b4dec451|concept
Improvements in curative and preventive care domains|4|condition|4cd87763e8f84bdc8f0067b2b4dec451|concept
Rehabilitative care|3|concept|4cd87763e8f84bdc8f0067b2b4dec451|concept
National Mental Health Policy 2014|4|document|4cd87763e8f84bdc8f0067b2b4dec451|concept
Vulnerable populations|3|concept|4cd87763e8f84bdc8f0067b2b4dec451|concept
Children|2|object|4cd87763e8f84bdc8f0067b2b4dec451|concept
Elderly|2|object|4cd87763e8f84bdc8f0067b2b4dec451|concept
Homeless|2|object|4cd87763e8f84bdc8f0067b2b4dec451|concept
Macro-environmental issues|4|concept|4cd87763e8f84bdc8f0067b2b4dec451|concept
Poverty|3|condition|4cd87763e8f84bdc8f0067b2b4dec451|concept
Unemployment|3|condition|4cd87763e8f84bdc8f0067b2b4dec451|concept
Displacement|2|condition|4cd87763e8f84bdc8f0067b2b4dec451|concept
Mental health impact of climate change|3|concept|4cd87763e8f84bdc8f0067b2b4dec451|concept
Leadership and governance|3|organisation|4cd87763e8f84bdc8f0067b2b4dec451|concept
World Mental Health Report, 2022|5|document|25ad6848459145afa5072490e52d8550|concept
interrelated services|4|concept|25ad6848459145afa5072490e52d8550|concept
life cycle|3|misc|25ad6848459145afa5072490e52d8550|concept
maternal and child mental health|2|concept|25ad6848459145afa5072490e52d8550|concept
elderly|2|condition|25ad6848459145afa5072490e52d8550|concept
Mental Health|5|concept|e7ce4dbfa7e046b6aba50e75ac56ef07|concept
LMICs|4|place|e7ce4dbfa7e046b6aba50e75ac56ef07|concept
Health Equity Assessment Toolkit (HEAT and HEAT Plus)|3|object|e7ce4dbfa7e046b6aba50e75ac56ef07|concept
High-Income Countries|4|place|e7ce4dbfa7e046b6aba50e75ac56ef07|concept
United Kingdom (UK)|3|place|e7ce4dbfa7e046b6aba50e75ac56ef07|concept
National Health Service (NHS)|2|object|e7ce4dbfa7e046b6aba50e75ac56ef07|concept
Five-Year Forward View for Mental Health|3|document|e7ce4dbfa7e046b6aba50e75ac56ef07|concept
Public Health Domain|3|misc|e7ce4dbfa7e046b6aba50e75ac56ef07|concept
Disparity Interventions|2|misc|e7ce4dbfa7e046b6aba50e75ac56ef07|concept
Inequality|4|condition|e7ce4dbfa7e046b6aba50e75ac56ef07|concept
private healthcare providers|4|organisation|d7a98a5523a14a81b33b3cadbeef1397|concept
non-communicable diseases|4|concept|d7a98a5523a14a81b33b3cadbeef1397|concept
chronic communicable diseases|3|condition|d7a98a5523a14a81b33b3cadbeef1397|concept
Tuberculosis|3|concept|d7a98a5523a14a81b33b3cadbeef1397|concept
multimorbidity|4|condition|d7a98a5523a14a81b33b3cadbeef1397|concept
National Programmes|3|organisation|d7a98a5523a14a81b33b3cadbeef1397|concept
non-communicable diseases programmes|2|concept|d7a98a5523a14a81b33b3cadbeef1397|concept
chronic communicable diseases programmes|2|concept|d7a98a5523a14a81b33b3cadbeef1397|concept
National Mission for Health and Family Welfare (NMHP)|4|organisation|d7a98a5523a14a81b33b3cadbeef1397|concept
primary care level|3|object|d7a98a5523a14a81b33b3cadbeef1397|concept
HWC (Health and Wellness Centers)|3|organisation|d7a98a5523a14a81b33b3cadbeef1397|concept
PM-JAY (Prime Minister's Jan Arogya Yojana)|4|object|d7a98a5523a14a81b33b3cadbeef1397|concept
patient reported outcomes|3|concept|d7a98a5523a14a81b33b3cadbeef1397|concept
clinical outcomes|3|concept|d7a98a5523a14a81b33b3cadbeef1397|concept
self-management interventions|2|object|d7a98a5523a14a81b33b3cadbeef1397|concept
peer-based interventions|2|concept|d7a98a5523a14a81b33b3cadbeef1397|concept
HICs (High Income Countries)|3|organisation|d7a98a5523a14a81b33b3cadbeef1397|concept
Accelerating Global Health: Pathways to Health Equity for the G20|5|event|644bde3f851d4926ba9d1fa8b25b904b|concept
cultural settings of LMICs|4|place|644bde3f851d4926ba9d1fa8b25b904b|concept
brief psychological interventions|3|concept|644bde3f851d4926ba9d1fa8b25b904b|concept
lay counsellors|4|organisation|644bde3f851d4926ba9d1fa8b25b904b|concept
moderate to severe depressive disorders and harmful drinking|3|condition|644bde3f851d4926ba9d1fa8b25b904b|concept
health systems in HICs|4|organisation|644bde3f851d4926ba9d1fa8b25b904b|concept
long waiting periods for psychological intervention|3|condition|644bde3f851d4926ba9d1fa8b25b904b|concept
low-intensity interventions|4|concept|644bde3f851d4926ba9d1fa8b25b904b|concept
Problem Management plus (PM+)|3|document|644bde3f851d4926ba9d1fa8b25b904b|concept
adults in distress due to exposure to adversity|4|condition|644bde3f851d4926ba9d1fa8b25b904b|concept
family caregivers|3|organisation|644bde3f851d4926ba9d1fa8b25b904b|concept
mental health|4|concept|644bde3f851d4926ba9d1fa8b25b904b|concept
indigenous interventions|3|misc|644bde3f851d4926ba9d1fa8b25b904b|concept
Yoga|4|object|644bde3f851d4926ba9d1fa8b25b904b|concept
alternative forms of medicine|3|misc|644bde3f851d4926ba9d1fa8b25b904b|concept
multimorbidity|4|condition|644bde3f851d4926ba9d1fa8b25b904b|concept
evidence-based integration|5|concept|78487c391631417992f97fcd77f0ba19|concept
public health system|4|place|78487c391631417992f97fcd77f0ba19|concept
cultural acceptance|3|condition|78487c391631417992f97fcd77f0ba19|concept
Tele-MANAS programme|4|organisation|78487c391631417992f97fcd77f0ba19|concept
digital literacy|3|condition|78487c391631417992f97fcd77f0ba19|concept
primary healthcare|4|place|78487c391631417992f97fcd77f0ba19|concept
Universal Health Coverage (UHC)|3|concept|78487c391631417992f97fcd77f0ba19|concept
referral pathways|2|misc|78487c391631417992f97fcd77f0ba19|concept
mental care|3|concept|78487c391631417992f97fcd77f0ba19|concept
physical care|2|misc|78487c391631417992f97fcd77f0ba19|concept
robust information systems|3|condition|78487c391631417992f97fcd77f0ba19|concept
mental and physical care integration|2|misc|78487c391631417992f97fcd77f0ba19|concept
equitable and quality healthcare|4|concept|996585f3b2fe4afe9aad026a32d48fe9|concept
Dr. Pratima Murthy|3|person|996585f3b2fe4afe9aad026a32d48fe9|concept
Director and Senior Professor of Psychiatry|2|position|996585f3b2fe4afe9aad026a32d48fe9|concept
NIMHANS, Bengaluru|3|organisation|996585f3b2fe4afe9aad026a32d48fe9|concept
Dr. Krishna Prasad Muliyala|2|person|996585f3b2fe4afe9aad026a32d48fe9|concept
Additional Professor of Psychiatry|1|position|996585f3b2fe4afe9aad026a32d48fe9|concept
Dr. Channaveerachari Naveen Kumar|2|person|996585f3b2fe4afe9aad026a32d48fe9|concept
Professor of Psychiatry and Head of Community Psychiatry|1|position|996585f3b2fe4afe9aad026a32d48fe9|concept
COVID-19 pandemic|5|event|8bf2b50e94df47b392aa512dbb2e74c1|concept
lockdown|4|concept|8bf2b50e94df47b392aa512dbb2e74c1|concept
global economy|3|event|8bf2b50e94df47b392aa512dbb2e74c1|concept
novel coronavirus|4|concept|8bf2b50e94df47b392aa512dbb2e74c1|concept
disease|3|concept|8bf2b50e94df47b392aa512dbb2e74c1|concept
zoonotic virus|2|concept|8bf2b50e94df47b392aa512dbb2e74c1|concept
Public Health Emergency of International Concern|3|event|8bf2b50e94df47b392aa512dbb2e74c1|concept
low-income countries|2|concept|8bf2b50e94df47b392aa512dbb2e74c1|concept
vaccines and drugs|3|object|8bf2b50e94df47b392aa512dbb2e74c1|concept
bird and animal viruses|5|concept|03a06fd2936d41afa48ec291c8bcbda8|concept
infectious disease|4|concept|03a06fd2936d41afa48ec291c8bcbda8|concept
epidemic|3|condition|03a06fd2936d41afa48ec291c8bcbda8|concept
pandemic|3|condition|03a06fd2936d41afa48ec291c8bcbda8|concept
prevent|2|concept|03a06fd2936d41afa48ec291c8bcbda8|concept
Barbara Stocking|1|person|03a06fd2936d41afa48ec291c8bcbda8|concept
The Urgent Need for a Pandemic Accord|2|document|03a06fd2936d41afa48ec291c8bcbda8|concept
Accelerating Global Health: Pathways to Health Equity for the G20|4|event|40998ca4b2594430b3f1f64aadfec89b|concept
COVID-19|5|event|40998ca4b2594430b3f1f64aadfec89b|concept
Healthcare systems|3|object|40998ca4b2594430b3f1f64aadfec89b|concept
Simulation exercises|2|event|40998ca4b2594430b3f1f64aadfec89b|concept
Public health system|3|object|40998ca4b2594430b3f1f64aadfec89b|concept
Lockdown|4|event|40998ca4b2594430b3f1f64aadfec89b|concept
Livelihoods and economy|3|condition|40998ca4b2594430b3f1f64aadfec89b|concept
Trade|2|event|40998ca4b2594430b3f1f64aadfec89b|concept
Social services (education)|2|object|40998ca4b2594430b3f1f64aadfec89b|concept
wait and see approach|2|concept|546a91dcc37740dfb8597967e1999249|concept
February 2020|3|event|546a91dcc37740dfb8597967e1999249|concept
International Health Regulations (IHR)|4|document|546a91dcc37740dfb8597967e1999249|concept
World Health Organization (WHO)|3|organisation|546a91dcc37740dfb8597967e1999249|concept
inequities between countries and population groups|4|concept|546a91dcc37740dfb8597967e1999249|concept
access to vaccines and drugs|3|concept|546a91dcc37740dfb8597967e1999249|concept
pandemic treaty|4|concept|546a91dcc37740dfb8597967e1999249|concept
World Health Assembly (WHA)|3|organisation|546a91dcc37740dfb8597967e1999249|concept
Pandemic Accord|5|concept|8a0b9edbbadd44c4babe8192a73bc83d|concept
WHO's 194 member states|3|organisation|8a0b9edbbadd44c4babe8192a73bc83d|concept
Intergovernmental Negotiating Body (INB)|2|organisation|8a0b9edbbadd44c4babe8192a73bc83d|concept
World Health Assembly (WHA)|4|event|8a0b9edbbadd44c4babe8192a73bc83d|concept
Working Group on amendments to the IHR (WGIHR)|3|organisation|8a0b9edbbadd44c4babe8192a73bc83d|concept
International Health Regulations (IHR)|4|document|8a0b9edbbadd44c4babe8192a73bc83d|concept
One Health|2|concept|8a0b9edbbadd44c4babe8192a73bc83d|concept
Equity in access to drugs and vaccines|3|condition|8a0b9edbbadd44c4babe8192a73bc83d|concept
WGIHR|4|organisation|b666ff6d8d3445a98869212995fcb597|concept
Pandemic Accord|4|document|b666ff6d8d3445a98869212995fcb597|concept
IHR|5|organisation|b666ff6d8d3445a98869212995fcb597|concept
One Health|3|concept|b666ff6d8d3445a98869212995fcb597|concept
Accelerating Global Health: Pathways to Health Equity for the G20|4|event|6e54c98b3b944682acb35e1bfe531831|concept
Solidarity|3|concept|6e54c98b3b944682acb35e1bfe531831|concept
United Nations Charter|2|document|6e54c98b3b944682acb35e1bfe531831|concept
vaccines, diagnostics and treatments|3|object|6e54c98b3b944682acb35e1bfe531831|concept
financing for these resources|2|condition|6e54c98b3b944682acb35e1bfe531831|concept
equity in governance systems|4|concept|9ccb6cad21444a27b7970917ba7e6c8b|concept
financing for preparedness and response to pandemics|3|concept|9ccb6cad21444a27b7970917ba7e6c8b|concept
donors|2|organisation|9ccb6cad21444a27b7970917ba7e6c8b|concept
equity|4|concept|9ccb6cad21444a27b7970917ba7e6c8b|concept
fairness|3|concept|9ccb6cad21444a27b7970917ba7e6c8b|concept
capabilities of countries|2|misc|9ccb6cad21444a27b7970917ba7e6c8b|concept
poorer countries|3|misc|9ccb6cad21444a27b7970917ba7e6c8b|concept
developed ones|2|misc|9ccb6cad21444a27b7970917ba7e6c8b|concept
transparency of data and genomic sequencing|4|concept|9ccb6cad21444a27b7970917ba7e6c8b|concept
quickly and effectively responding to the pandemic|3|misc|9ccb6cad21444a27b7970917ba7e6c8b|concept
development of new drugs and vaccines|2|concept|9ccb6cad21444a27b7970917ba7e6c8b|concept
trust within and between countries|3|misc|9ccb6cad21444a27b7970917ba7e6c8b|concept
accountability requirements|4|concept|9ccb6cad21444a27b7970917ba7e6c8b|concept
past Accord|2|misc|9ccb6cad21444a27b7970917ba7e6c8b|concept
Pandemic Accord|4|concept|50ba14851d3f4a95ac0e459eb61a0f50|concept
IHR|3|concept|50ba14851d3f4a95ac0e459eb61a0f50|concept
civil society organisations|3|organisation|50ba14851d3f4a95ac0e459eb61a0f50|concept
parliamentary systems|3|organisation|50ba14851d3f4a95ac0e459eb61a0f50|concept
zero draft|2|document|50ba14851d3f4a95ac0e459eb61a0f50|concept
first draft|2|document|50ba14851d3f4a95ac0e459eb61a0f50|concept
Accord|5|event|bc526127448645b3837dcc3b45668a83|concept
Human Rights Protection|4|concept|bc526127448645b3837dcc3b45668a83|concept
Public Health and Healthcare Systems|3|object|bc526127448645b3837dcc3b45668a83|concept
Staff Protection|4|misc|bc526127448645b3837dcc3b45668a83|concept
Misinformation Management|3|event|bc526127448645b3837dcc3b45668a83|concept
Whole-of-Society Approach|4|concept|bc526127448645b3837dcc3b45668a83|concept
Global Coordination|3|event|bc526127448645b3837dcc3b45668a83|concept
Preparedness Plans|4|event|bc526127448645b3837dcc3b45668a83|concept
Simulation Exercises|3|event|bc526127448645b3837dcc3b45668a83|concept
Universal Health and Preparedness Review|4|document|bc526127448645b3837dcc3b45668a83|concept
plans|3|concept|5e2a17a4edaa487290ad2532cd863fd8|concept
independent assessment|2|concept|5e2a17a4edaa487290ad2532cd863fd8|concept
public health response|3|concept|5e2a17a4edaa487290ad2532cd863fd8|concept
IHR|2|organisation|5e2a17a4edaa487290ad2532cd863fd8|concept
Accelerating Global Health|5|event|83977ec929b94ecc86a6c51a35fa39cf|concept
Pathways to Health Equity for the G20|5|event|83977ec929b94ecc86a6c51a35fa39cf|concept
one health|4|concept|83977ec929b94ecc86a6c51a35fa39cf|concept
zoonoses|3|condition|83977ec929b94ecc86a6c51a35fa39cf|concept
wet markets|2|place|83977ec929b94ecc86a6c51a35fa39cf|concept
Joint Plan of Action|3|document|83977ec929b94ecc86a6c51a35fa39cf|concept
equity|4|condition|83977ec929b94ecc86a6c51a35fa39cf|concept
access to vaccines, drugs, and other medical equipment|5|event|c4ed77f811a94b6b8d85279085b53df5|concept
 Member states|4|concept|c4ed77f811a94b6b8d85279085b53df5|concept
differences among them|3|condition|c4ed77f811a94b6b8d85279085b53df5|concept
Developing countries|4|concept|c4ed77f811a94b6b8d85279085b53df5|concept
wider spread of manufacturing|3|event|c4ed77f811a94b6b8d85279085b53df5|concept
Success in getting mRNA vaccine manufacturing underway in South Africa|4|event|c4ed77f811a94b6b8d85279085b53df5|concept
manufacturing for the whole continent and globally|3|event|c4ed77f811a94b6b8d85279085b53df5|concept
financial investment|4|condition|c4ed77f811a94b6b8d85279085b53df5|concept
technology transfer|3|event|c4ed77f811a94b6b8d85279085b53df5|concept
pharmaceutical industry|4|organisation|c4ed77f811a94b6b8d85279085b53df5|concept
technology transfer and the associated question of intellectual property rights|3|condition|c4ed77f811a94b6b8d85279085b53df5|concept
wealthier governments funding R&D|4|event|c4ed77f811a94b6b8d85279085b53df5|concept
companies earmark a percentage of vaccines for the poorer countries or sell to them at cost|3|event|c4ed77f811a94b6b8d85279085b53df5|concept
pharmaceutical industry|4|organisation|1a4820465fa844f8901275aa62a66e82|concept
infectious diseases|3|condition|1a4820465fa844f8901275aa62a66e82|concept
Pandemic Accord|5|concept|abe8dec679a3446db21c31d36bcd3b12|concept
World Trade Organization|3|organisation|abe8dec679a3446db21c31d36bcd3b12|concept
TRIPS waiver|4|concept|abe8dec679a3446db21c31d36bcd3b12|concept
Doha Trade Round|3|event|abe8dec679a3446db21c31d36bcd3b12|concept
equity of access|4|concept|abe8dec679a3446db21c31d36bcd3b12|concept
Pandemic Accord and the IHR|3|misc|abe8dec679a3446db21c31d36bcd3b12|concept
financing|4|concept|abe8dec679a3446db21c31d36bcd3b12|concept
G20 Independent High-Level Panel|3|organisation|abe8dec679a3446db21c31d36bcd3b12|concept
annual financing need for future preparedness and response to pandemics|4|concept|abe8dec679a3446db21c31d36bcd3b12|concept
PPR|2|organisation|abe8dec679a3446db21c31d36bcd3b12|concept
health systems|4|concept|c410a5c9df2e4df2998153d58af3836c|concept
R&D|3|concept|c410a5c9df2e4df2998153d58af3836c|concept
overall preparedness|4|concept|c410a5c9df2e4df2998153d58af3836c|concept
G20 report|3|document|c410a5c9df2e4df2998153d58af3836c|concept
Pandemic Fund at the World Bank|4|organisation|c410a5c9df2e4df2998153d58af3836c|concept
IHR|3|concept|c410a5c9df2e4df2998153d58af3836c|concept
Accountability|4|misc|c410a5c9df2e4df2998153d58af3836c|concept
Accord|3|concept|c410a5c9df2e4df2998153d58af3836c|concept
external accountability mechanisms|4|misc|c410a5c9df2e4df2998153d58af3836c|concept
independent assessment of countries|3|concept|c410a5c9df2e4df2998153d58af3836c|concept
Accord|4|event|c134e5a2812f44f9803c15d7591765a0|concept
WHO|3|organisation|c134e5a2812f44f9803c15d7591765a0|concept
Accord|4|event|42c1df8501c946858051c31ad52c5ec5|concept
IHR|3|concept|42c1df8501c946858051c31ad52c5ec5|concept
WHO|4|organisation|42c1df8501c946858051c31ad52c5ec5|concept
International Atomic Energy Agency (IAEA)|3|organisation|42c1df8501c946858051c31ad52c5ec5|concept
public space|3|misc|42c1df8501c946858051c31ad52c5ec5|concept
independent assessment body|4|organisation|42c1df8501c946858051c31ad52c5ec5|concept
monitoring information|3|misc|42c1df8501c946858051c31ad52c5ec5|concept
pandemics|4|event|42c1df8501c946858051c31ad52c5ec5|concept
governments|3|misc|42c1df8501c946858051c31ad52c5ec5|concept
Global Public Health Convention|5|event|d4d6f26b296047fabb3e74cec31ebc41|concept
countries across the world|4|organisation|d4d6f26b296047fabb3e74cec31ebc41|concept
resources to deliver|3|condition|d4d6f26b296047fabb3e74cec31ebc41|concept
Dame Barbara Stocking|4|person|d4d6f26b296047fabb3e74cec31ebc41|concept
Panel for a Global Public Health Convention|3|organisation|d4d6f26b296047fabb3e74cec31ebc41|concept
investments in future|3|concept|f21a0cbf122d44f599f9b52ccec5f521|concept
Ensuring Equitable Supply and Access|2|concept|f21a0cbf122d44f599f9b52ccec5f521|concept
Critical Vaccines|3|concept|f21a0cbf122d44f599f9b52ccec5f521|concept
Pandemics|4|concept|f21a0cbf122d44f599f9b52ccec5f521|concept
COV AX Aurélia Nguyen|2|misc|f21a0cbf122d44f599f9b52ccec5f521|concept
pandemic|5|event|7aa69007cfd442f9822d3663a6c4c65a|concept
health systems|4|concept|7aa69007cfd442f9822d3663a6c4c65a|concept
COVAX Facility|3|organisation|7aa69007cfd442f9822d3663a6c4c65a|concept
Access to COVID-19 Tools Accelerator (ACT-A)|4|concept|7aa69007cfd442f9822d3663a6c4c65a|concept
COVAX|3|organisation|7aa69007cfd442f9822d3663a6c4c65a|concept
Coalition for Epidemic Preparedness Innovations (CEPI)|2|organisation|7aa69007cfd442f9822d3663a6c4c65a|concept
World Health Organization (WHO)|4|organisation|7aa69007cfd442f9822d3663a6c4c65a|concept
United Nations Children’s Fund (UNICEF)|3|organisation|7aa69007cfd442f9822d3663a6c4c65a|concept
Gavi, the Vaccine Alliance|5|organisation|3c76d07238434794b3a491927cbf70e4|concept
COVAX AMC|4|organisation|3c76d07238434794b3a491927cbf70e4|concept
Imperial College London|3|organisation|3c76d07238434794b3a491927cbf70e4|concept
COVID-19 vaccinations|4|concept|3c76d07238434794b3a491927cbf70e4|concept
conditions|3|condition|3c76d07238434794b3a491927cbf70e4|concept
pandemic|4|concept|3c76d07238434794b3a491927cbf70e4|concept
Accelerating Global Health|3|event|80889f7b0eaa4090934f8879b238d535|concept
Pathways to Health Equity for the G20|4|concept|80889f7b0eaa4090934f8879b238d535|concept
procurement, distribution, administration of COVID-19 vaccines|5|misc|80889f7b0eaa4090934f8879b238d535|concept
COVID-19|4|event|80889f7b0eaa4090934f8879b238d535|concept
COVAX|3|organisation|80889f7b0eaa4090934f8879b238d535|concept
vaccine makers|4|organisation|80889f7b0eaa4090934f8879b238d535|concept
bilateral customers|3|misc|80889f7b0eaa4090934f8879b238d535|concept
vaccine candidates|5|concept|4d3ad7c8415c4169b650d2f3754e263d|concept
COVAX|4|organisation|4d3ad7c8415c4169b650d2f3754e263d|concept
export bans|3|misc|4d3ad7c8415c4169b650d2f3754e263d|concept
global health agencies|4|organisation|4d3ad7c8415c4169b650d2f3754e263d|concept
COVAX Facility|3|organisation|4d3ad7c8415c4169b650d2f3754e263d|concept
recommendations|4|misc|895f9a65a28c496595bb295596c4fdd1|concept
supply|4|concept|895f9a65a28c496595bb295596c4fdd1|concept
demand|4|concept|895f9a65a28c496595bb295596c4fdd1|concept
R&D|5|concept|895f9a65a28c496595bb295596c4fdd1|concept
manufacturing|4|concept|895f9a65a28c496595bb295596c4fdd1|concept
country-level challenges|5|misc|895f9a65a28c496595bb295596c4fdd1|concept
other factors|4|misc|895f9a65a28c496595bb295596c4fdd1|concept
at-risk investments|5|misc|895f9a65a28c496595bb295596c4fdd1|concept
funding|4|concept|895f9a65a28c496595bb295596c4fdd1|concept
vaccines|5|object|895f9a65a28c496595bb295596c4fdd1|concept
R&D stage|4|misc|895f9a65a28c496595bb295596c4fdd1|concept
COVAX|4|organisation|19c06e9b16344d5f98aae0410d469d9c|concept
pandemic vaccine pool (PVP)|3|organisation|19c06e9b16344d5f98aae0410d469d9c|concept
lower-income countries|2|place|19c06e9b16344d5f98aae0410d469d9c|concept
vaccine candidates|3|misc|19c06e9b16344d5f98aae0410d469d9c|concept
COVID-19|4|event|19c06e9b16344d5f98aae0410d469d9c|concept
multinational trade-facilitation measures|3|organisation|19c06e9b16344d5f98aae0410d469d9c|concept
life-saving equipment|5|object|f85f8a3779d1458a97ac8d5f13f782d0|concept
health emergencies|4|event|f85f8a3779d1458a97ac8d5f13f782d0|concept
exemptions and waivers|3|concept|f85f8a3779d1458a97ac8d5f13f782d0|concept
trade barriers|3|condition|f85f8a3779d1458a97ac8d5f13f782d0|concept
life-saving medical countermeasures and materials|4|object|f85f8a3779d1458a97ac8d5f13f782d0|concept
low- and middle-income countries|3|organisation|f85f8a3779d1458a97ac8d5f13f782d0|concept
humanitarian situations|4|event|f85f8a3779d1458a97ac8d5f13f782d0|concept
vaccines|5|object|f85f8a3779d1458a97ac8d5f13f782d0|concept
vaccinations|4|concept|f85f8a3779d1458a97ac8d5f13f782d0|concept
strong, reliable health systems|4|concept|f85f8a3779d1458a97ac8d5f13f782d0|concept
early R&D|3|concept|f85f8a3779d1458a97ac8d5f13f782d0|concept
scaling-up manufacturing|4|concept|f85f8a3779d1458a97ac8d5f13f782d0|concept
securing deals|3|concept|f85f8a3779d1458a97ac8d5f13f782d0|concept
consistent policy guidance|3|concept|f85f8a3779d1458a97ac8d5f13f782d0|concept
operational, logistical, regulatory, and legal frameworks|4|concept|f85f8a3779d1458a97ac8d5f13f782d0|concept
ancillary supplies|3|object|f85f8a3779d1458a97ac8d5f13f782d0|concept
cold chain|3|object|f85f8a3779d1458a97ac8d5f13f782d0|concept
safe injection equipment|3|object|f85f8a3779d1458a97ac8d5f13f782d0|concept
international freight and logistics|3|organisation|f85f8a3779d1458a97ac8d5f13f782d0|concept
in-country delivery requirements|5|event|7b0a4ad9437f45829cb41258f4f78a71|concept
personal protective equipment for healthcare workers|4|object|7b0a4ad9437f45829cb41258f4f78a71|concept
countries lacking infrastructure|3|condition|7b0a4ad9437f45829cb41258f4f78a71|concept
Gavi and WHO|4|organisation|7b0a4ad9437f45829cb41258f4f78a71|concept
Accelerating Global Health|3|event|4b38bb5b7e7343dc87ddf380cad54595|concept
Pathways to Health Equity for the G20|3|event|4b38bb5b7e7343dc87ddf380cad54595|concept
cold chains|3|object|4b38bb5b7e7343dc87ddf380cad54595|concept
immunisation programmes|4|concept|4b38bb5b7e7343dc87ddf380cad54595|concept
Gavi|3|organisation|4b38bb5b7e7343dc87ddf380cad54595|concept
lower-income countries' routine immunisation programmes|4|concept|4b38bb5b7e7343dc87ddf380cad54595|concept
COVID-19 vaccines|3|object|4b38bb5b7e7343dc87ddf380cad54595|concept
extra burden of delivering COVID-19 vaccines to other populations|2|misc|4b38bb5b7e7343dc87ddf380cad54595|concept
efforts to vaccinate mostly children|3|misc|4b38bb5b7e7343dc87ddf380cad54595|concept
relatively little decline in routine immunisation|2|misc|4b38bb5b7e7343dc87ddf380cad54595|concept
vaccinators, doctors and nurses were burned out|3|misc|4b38bb5b7e7343dc87ddf380cad54595|concept
immunisation in Gavi-implementing countries|2|misc|4b38bb5b7e7343dc87ddf380cad54595|concept
COVID-19|5|event|c34ec7b0256847df9acfe84b02149252|concept
Health system strengthening investments|4|concept|c34ec7b0256847df9acfe84b02149252|concept
Primary healthcare services|3|concept|c34ec7b0256847df9acfe84b02149252|concept
Cold chain|2|object|c34ec7b0256847df9acfe84b02149252|concept
Vaccine track-and-trace|3|concept|c34ec7b0256847df9acfe84b02149252|concept
Human resources|2|object|c34ec7b0256847df9acfe84b02149252|concept
Data monitoring systems|3|concept|c34ec7b0256847df9acfe84b02149252|concept
COVID-19 vaccine Delivery Support (CDS)|4|organisation|c34ec7b0256847df9acfe84b02149252|concept
Gavi|3|organisation|c34ec7b0256847df9acfe84b02149252|concept
COVAX|5|organisation|0e304bf478d4428e929abad5c796e272|concept
Gavi-implementing countries|4|place|0e304bf478d4428e929abad5c796e272|concept
routine immunisation|3|concept|0e304bf478d4428e929abad5c796e272|concept
COVID-19 vaccine coverage|4|condition|0e304bf478d4428e929abad5c796e272|concept
pandemic preparedness|3|concept|0e304bf478d4428e929abad5c796e272|concept
most vulnerable people|4|misc|0e304bf478d4428e929abad5c796e272|concept
equitable supply of vaccines|3|concept|0e304bf478d4428e929abad5c796e272|concept
vaccine nationalism|5|misc|27df9e2ca46243ad8d81ff5a54a1fb00|concept
hoarding|4|misc|27df9e2ca46243ad8d81ff5a54a1fb00|concept
export bans|3|misc|27df9e2ca46243ad8d81ff5a54a1fb00|concept
COVAX Facility|5|organisation|27df9e2ca46243ad8d81ff5a54a1fb00|concept
H1N1 pandemic|4|event|27df9e2ca46243ad8d81ff5a54a1fb00|concept
vaccines|5|object|27df9e2ca46243ad8d81ff5a54a1fb00|concept
lower-income economies|3|misc|27df9e2ca46243ad8d81ff5a54a1fb00|concept
wealthier nations|4|misc|27df9e2ca46243ad8d81ff5a54a1fb00|concept
COVID-19 vaccines|5|object|27df9e2ca46243ad8d81ff5a54a1fb00|concept
vaccine-candidates|4|misc|27df9e2ca46243ad8d81ff5a54a1fb00|concept
technology platforms|3|misc|27df9e2ca46243ad8d81ff5a54a1fb00|concept
regulatory approval|3|event|27df9e2ca46243ad8d81ff5a54a1fb00|concept
large-scale investments|4|misc|27df9e2ca46243ad8d81ff5a54a1fb00|concept
COVAX portfolio|4|organisation|27df9e2ca46243ad8d81ff5a54a1fb00|concept
191 countries|2|misc|27df9e2ca46243ad8d81ff5a54a1fb00|concept
COVAX|5|organisation|55b09ec3abaf48e98355f0d359b46caf|concept
finite supply of vaccine doses|3|condition|55b09ec3abaf48e98355f0d359b46caf|concept
H1N1 vaccine|2|concept|55b09ec3abaf48e98355f0d359b46caf|concept
Accelerating Global Health|4|event|d4a21a81d74e413ba4d349be59d06804|concept
Pathways to Health Equity for the G20|3|event|d4a21a81d74e413ba4d349be59d06804|concept
COVID-19 pandemic|5|event|d4a21a81d74e413ba4d349be59d06804|concept
vaccine manufacturing|4|object|d4a21a81d74e413ba4d349be59d06804|concept
African continent|2|place|d4a21a81d74e413ba4d349be59d06804|concept
Africa Center for Disease Control|2|organisation|d4a21a81d74e413ba4d349be59d06804|concept
Memorandum of Understanding|3|event|d4a21a81d74e413ba4d349be59d06804|concept
Gavi|2|organisation|d4a21a81d74e413ba4d349be59d06804|concept
African Union Commission|2|organisation|d4a21a81d74e413ba4d349be59d06804|concept
sustainable regional vaccine manufacturing|4|event|d07c2d94246f4df795c7be6170d78db1|concept
commitments to increase political, financial, and technical investments in immunisation programmes|4|event|d07c2d94246f4df795c7be6170d78db1|concept
models for ensuring lower-income countries receive vaccine doses|3|event|d07c2d94246f4df795c7be6170d78db1|concept
manufacturers' transparency about their order books|4|event|d07c2d94246f4df795c7be6170d78db1|concept
supply inequities among countries|3|condition|d07c2d94246f4df795c7be6170d78db1|concept
contingent financing for pandemic response|4|event|d07c2d94246f4df795c7be6170d78db1|concept
COVAX AMC funding|3|document|d07c2d94246f4df795c7be6170d78db1|concept
PVP funding|3|organisation|d7a7913899f445febee6bff8c39924bc|concept
variant-containing vaccine boosters|4|object|d7a7913899f445febee6bff8c39924bc|concept
2024–25 COVID-19 programme|4|event|d7a7913899f445febee6bff8c39924bc|concept
Gavi board|3|organisation|d7a7913899f445febee6bff8c39924bc|concept
COVAX|5|organisation|54d16e33cfb44174b61da49448891293|concept
Gavi, the Vaccine Alliance|4|organisation|54d16e33cfb44174b61da49448891293|concept
Aurélia Nguyen|3|person|54d16e33cfb44174b61da49448891293|concept
Global Vaccine Library|4|concept|0cd02fb084694bbca463dd2b114f1d48|concept
coronavirus|5|organisation|0cd02fb084694bbca463dd2b114f1d48|concept
spike protein|4|concept|0cd02fb084694bbca463dd2b114f1d48|concept
neutralising antibodies|3|concept|0cd02fb084694bbca463dd2b114f1d48|concept
RSV|4|organisation|0cd02fb084694bbca463dd2b114f1d48|concept
SARS|4|organisation|0cd02fb084694bbca463dd2b114f1d48|concept
MERS|4|organisation|0cd02fb084694bbca463dd2b114f1d48|concept
security bodies|3|organisation|d7a7df237a9b4336b1e40e727ecdd5c9|concept
smallpox vaccines|4|object|d7a7df237a9b4336b1e40e727ecdd5c9|concept
Mpox|3|concept|d7a7df237a9b4336b1e40e727ecdd5c9|concept
2022 Mpox epidemic|4|event|d7a7df237a9b4336b1e40e727ecdd5c9|concept
Accelerating Global Health|3|event|7a57613761f64fe58fbc8709d4670828|concept
Pathways to Health Equity for the G20|3|event|7a57613761f64fe58fbc8709d4670828|concept
Viral Threats|3|concept|7a57613761f64fe58fbc8709d4670828|concept
Infectious Pathogens|4|concept|7a57613761f64fe58fbc8709d4670828|concept
Containment Race|3|event|7a57613761f64fe58fbc8709d4670828|concept
Pandemic Control|4|concept|7a57613761f64fe58fbc8709d4670828|concept
Coalition for Epidemic Preparedness Innovations (CEPI)|3|organisation|7a57613761f64fe58fbc8709d4670828|concept
One World Vaccine Library|4|document|7a57613761f64fe58fbc8709d4670828|concept
global community|5|organisation|58efa624d5c4493eb9e220aab122325c|concept
health security|4|concept|58efa624d5c4493eb9e220aab122325c|concept
pandemic threats|3|event|58efa624d5c4493eb9e220aab122325c|concept
vaccines|4|object|58efa624d5c4493eb9e220aab122325c|concept
dangerous and deadly outbreaks|2|event|58efa624d5c4493eb9e220aab122325c|concept
incipient pandemic|3|event|58efa624d5c4493eb9e220aab122325c|concept
potential opponents|2|concept|58efa624d5c4493eb9e220aab122325c|concept
viruses from around 25 viral families|3|organisation|58efa624d5c4493eb9e220aab122325c|concept
One World Vaccine Library|3|misc|dc468156950d4a4d8a8878e75499afa3|concept
viral-family-based prototype vaccine approach|4|concept|dc468156950d4a4d8a8878e75499afa3|concept
Accelerating Global Health|5|event|0b579a5b26e9407a902cb29529089cee|concept
Pathways to Health Equity for the G20|4|event|0b579a5b26e9407a902cb29529089cee|concept
novel paramyxovirus|3|concept|0b579a5b26e9407a902cb29529089cee|concept
One World Vaccine Library|5|object|0b579a5b26e9407a902cb29529089cee|concept
Develop vaccines|3|event|cc987a2a91d846c5a1d952ecc309cc62|concept
Researchers|2|organisation|cc987a2a91d846c5a1d952ecc309cc62|concept
New outbreak and virus|2|event|cc987a2a91d846c5a1d952ecc309cc62|concept
Genome sequencing|3|concept|cc987a2a91d846c5a1d952ecc309cc62|concept
One World Vaccine Library|4|object|cc987a2a91d846c5a1d952ecc309cc62|concept
CEPI|3|organisation|cc987a2a91d846c5a1d952ecc309cc62|concept
Virus families|2|concept|cc987a2a91d846c5a1d952ecc309cc62|concept
Disease X|3|concept|cc987a2a91d846c5a1d952ecc309cc62|concept
Vaccine library candidates|3|object|cc987a2a91d846c5a1d952ecc309cc62|concept
clinical testing|4|event|f82e8abf722e423ba48ded1798296b13|concept
safety|3|condition|f82e8abf722e423ba48ded1798296b13|concept
immunogenicity|4|concept|f82e8abf722e423ba48ded1798296b13|concept
platform|3|object|f82e8abf722e423ba48ded1798296b13|concept
antigens|2|object|f82e8abf722e423ba48ded1798296b13|concept
lead candidates|4|organisation|f82e8abf722e423ba48ded1798296b13|concept
families|3|misc|f82e8abf722e423ba48ded1798296b13|concept
clinical proof of concept|4|concept|f82e8abf722e423ba48ded1798296b13|concept
One World Vaccine Library|5|object|8cb3bc020aed4d0a86a05c1f658e2708|concept
100 Days Mission|4|event|8cb3bc020aed4d0a86a05c1f658e2708|concept
CEPI's 100 Days Mission|3|concept|8cb3bc020aed4d0a86a05c1f658e2708|concept
G7 and the G20|3|organisation|8cb3bc020aed4d0a86a05c1f658e2708|concept
Disease X pandemic virus|4|condition|8cb3bc020aed4d0a86a05c1f658e2708|concept
new vaccines|3|object|8cb3bc020aed4d0a86a05c1f658e2708|concept
improved surveillance|2|condition|8cb3bc020aed4d0a86a05c1f658e2708|concept
non-pharmaceutical interventions|3|misc|8cb3bc020aed4d0a86a05c1f658e2708|concept
One World Vaccine Library|5|concept|f5b55f34587246179c6c6d2bc0801141|concept
virus families|4|concept|f5b55f34587246179c6c6d2bc0801141|concept
pandemics|3|concept|f5b55f34587246179c6c6d2bc0801141|concept
100 Days Mission|2|event|f5b55f34587246179c6c6d2bc0801141|concept
pandemics|5|event|4160fb9924f24b5eb68e493cd9361060|concept
Dr. Richard Hatchett|4|person|4160fb9924f24b5eb68e493cd9361060|concept
Coalition for Epidemic Preparedness Innovations (CEPI)|5|organisation|4160fb9924f24b5eb68e493cd9361060|concept
Kate Kelland|3|person|4160fb9924f24b5eb68e493cd9361060|concept
Public Health Workforce|5|concept|732fe967002642599669103e63f2f22a|concept
COVID-19 pandemic|4|event|732fe967002642599669103e63f2f22a|concept
Public Health System|3|object|732fe967002642599669103e63f2f22a|concept
Essential health services|2|object|732fe967002642599669103e63f2f22a|concept
Routine immunisation|1|object|732fe967002642599669103e63f2f22a|concept
Disease outbreaks|2|event|732fe967002642599669103e63f2f22a|concept
limited availability of the health workforce|5|event|3dcdf4837b764370bb2cf1e2776825cc|concept
COVID-19 infections and deaths among health workers|4|event|3dcdf4837b764370bb2cf1e2776825cc|concept
mental health issues, including burnout|3|condition|3dcdf4837b764370bb2cf1e2776825cc|concept
poor working conditions|3|condition|3dcdf4837b764370bb2cf1e2776825cc|concept
protracted conflicts|2|event|3dcdf4837b764370bb2cf1e2776825cc|concept
global increase in climate-related and humanitarian disasters|2|event|3dcdf4837b764370bb2cf1e2776825cc|concept
public health crisis|3|event|3dcdf4837b764370bb2cf1e2776825cc|concept
reversals in life expectancy and Sustainable Development Goals|2|condition|3dcdf4837b764370bb2cf1e2776825cc|concept
Investing in the Public Health Workforce|5|concept|c9d7fdd45c4e4061ac050c6a21b2f583|concept
Essential Public Health Functiona (EPHF)|5|concept|c9d7fdd45c4e4061ac050c6a21b2f583|concept
Global investment|5|misc|c9d7fdd45c4e4061ac050c6a21b2f583|concept
G7 and G20 intergovernmental processes|4|event|c9d7fdd45c4e4061ac050c6a21b2f583|concept
World Health Organization (WHO)|5|organization|c9d7fdd45c4e4061ac050c6a21b2f583|concept
regional, and global bodies|5|organisation|525f8e57fb164f289fed4c4155309473|concept
G20|4|organisation|525f8e57fb164f289fed4c4155309473|concept
G7|4|organisation|525f8e57fb164f289fed4c4155309473|concept
COVID-19 pandemic|3|event|525f8e57fb164f289fed4c4155309473|concept
EPHFs (Emergency Public Health Functions)|2|concept|525f8e57fb164f289fed4c4155309473|concept
World Federation of Public Health Associations (WFPHA), International|2|organisation|525f8e57fb164f289fed4c4155309473|concept
Association of National Public Health Institutions (IANPHI)|4|organisation|99d0ffec664a4147b99327b232eec755|concept
Global Network Academic Schools of Public Health (GNASPH).|3|organisation|99d0ffec664a4147b99327b232eec755|concept
Global Health Summit|5|event|2106f61eb09845f7855d15da890e67ae|concept
Rome Declaration|4|document|2106f61eb09845f7855d15da890e67ae|concept
G20 Italia Declaration of Health Ministers|3|document|2106f61eb09845f7855d15da890e67ae|concept
health workforce|5|misc|5837ba13e7f942cf8b17ebfcaef29429|concept
COVID-19|4|event|5837ba13e7f942cf8b17ebfcaef29429|concept
G7 Summit|4|event|5837ba13e7f942cf8b17ebfcaef29429|concept
Carbis Bay Health Declaration|3|document|5837ba13e7f942cf8b17ebfcaef29429|concept
G7 Germany|2|event|5837ba13e7f942cf8b17ebfcaef29429|concept
pandemic preparedness and response|4|concept|1ef5b0e99e864a539d6ef6e41039de13|concept
G7 Pact for Pandemic Readiness|3|organisation|1ef5b0e99e864a539d6ef6e41039de13|concept
Berlin|2|place|1ef5b0e99e864a539d6ef6e41039de13|concept
low- and lower-middle income countries (LMICs)|3|concept|1ef5b0e99e864a539d6ef6e41039de13|concept
Public Health Workforce|4|concept|58263ccaef7b48289de7a0d400d6d13d|concept
pandemic preparedness and response|3|concept|58263ccaef7b48289de7a0d400d6d13d|concept
WHO|4|organisation|58263ccaef7b48289de7a0d400d6d13d|concept
Strengthening the Global Architecture for Health Emergency Preparedness and Response (HEPR)|3|document|58263ccaef7b48289de7a0d400d6d13d|concept
G7 Roadmap|2|document|58263ccaef7b48289de7a0d400d6d13d|concept
International Health Regulation (IHR 2005)|3|document|58263ccaef7b48289de7a0d400d6d13d|concept
G7 Pact|2|misc|58263ccaef7b48289de7a0d400d6d13d|concept
Pandemic Fund|3|object|58263ccaef7b48289de7a0d400d6d13d|concept
Impact Investment Initiative for Global Health|3|event|7cb2165fcdc945c6ae0860e59f189275|concept
United Nations' three High-Level Meetings|4|event|7cb2165fcdc945c6ae0860e59f189275|concept
Global South|3|place|7cb2165fcdc945c6ae0860e59f189275|concept
non-communicable and communicable diseases|2|condition|7cb2165fcdc945c6ae0860e59f189275|concept
PPR|2|condition|7cb2165fcdc945c6ae0860e59f189275|concept
Essential health services|3|object|7cb2165fcdc945c6ae0860e59f189275|concept
Public health workforce|4|organisation|7cb2165fcdc945c6ae0860e59f189275|concept
G20 and the G7 processes|3|event|7cb2165fcdc945c6ae0860e59f189275|concept
12 essential public health functions|2|concept|7cb2165fcdc945c6ae0860e59f189275|concept
roadmap|4|plan|c758753adaf94ea9a1978600c51ad623|concept
national public health workforce capacity|5|concept|c758753adaf94ea9a1978600c51ad623|concept
EPHFs|4|event|c758753adaf94ea9a1978600c51ad623|concept
emergency preparedness and response|3|concept|c758753adaf94ea9a1978600c51ad623|concept
public health workforce|4|organisation|c758753adaf94ea9a1978600c51ad623|concept
Public Health Workforce|5|concept|b5e8fd8bf09244c9a74995e5e618f489|concept
occupations outside of the health sector|4|misc|b5e8fd8bf09244c9a74995e5e618f489|concept
Global partners|3|organisation|b5e8fd8bf09244c9a74995e5e618f489|concept
roadmap and action plan|4|document|b5e8fd8bf09244c9a74995e5e618f489|concept
standard EPHF|3|concept|b5e8fd8bf09244c9a74995e5e618f489|concept
whole-of-government and whole-of-society approach|4|misc|b5e8fd8bf09244c9a74995e5e618f489|concept
national stakeholders|3|organisation|b5e8fd8bf09244c9a74995e5e618f489|concept
existing national and global networks of partners|4|misc|b5e8fd8bf09244c9a74995e5e618f489|concept
country-based assessment|3|event|b5e8fd8bf09244c9a74995e5e618f489|concept
policy improvement|4|concept|b5e8fd8bf09244c9a74995e5e618f489|concept
workforce capacity and readiness|5|concept|0cb51c16f7fe42cb9f4ad07e5e6ab337|concept
national assessments and benchmarking|4|event|0cb51c16f7fe42cb9f4ad07e5e6ab337|concept
G20 support to invest in preparedness and national capacity|5|event|0cb51c16f7fe42cb9f4ad07e5e6ab337|concept
World Bank’s Pandemic Fund|4|organization|0cb51c16f7fe42cb9f4ad07e5e6ab337|concept
strengthening human resources|5|concept|0cb51c16f7fe42cb9f4ad07e5e6ab337|concept
countries prevent, prepare for, and respond to health emergencies|4|event|0cb51c16f7fe42cb9f4ad07e5e6ab337|concept
sustainable public health workforce capacity in LMICs|5|concept|0cb51c16f7fe42cb9f4ad07e5e6ab337|concept
alignment with the ongoing governance processes of IHR 2005 amendments and negotiations on a global pandemic accord|4|event|0cb51c16f7fe42cb9f4ad07e5e6ab337|concept
Intergovernmental Negotiating Body (INB) on a new WHO convention, agreement, or other international instruments on PPR (WHO CA+)|3|organization|0cb51c16f7fe42cb9f4ad07e5e6ab337|concept
WHO|3|organisation|503ecc2f98c64e4ba8733349b9834adc|concept
convention, agreement, international instrument|4|event|503ecc2f98c64e4ba8733349b9834adc|concept
PPR (WHO CA+)|3|condition|503ecc2f98c64e4ba8733349b9834adc|concept
International Health Regulation|2|document|503ecc2f98c64e4ba8733349b9834adc|concept
amendments|3|event|503ecc2f98c64e4ba8733349b9834adc|concept
Accelerating Global Health|4|concept|0ed58dcdb4a043718b2c6e0652992e78|concept
Pathways to Health Equity for the G20|4|concept|0ed58dcdb4a043718b2c6e0652992e78|concept
Role of India's G20 Presidency|3|event|0ed58dcdb4a043718b2c6e0652992e78|concept
intergovernmental consensus and commitment for public health strengthening|4|concept|0ed58dcdb4a043718b2c6e0652992e78|concept
public health workforce needs|3|concept|0ed58dcdb4a043718b2c6e0652992e78|concept
G20 in India|3|event|0ed58dcdb4a043718b2c6e0652992e78|concept
SDGs and global health architecture for PPR|4|concept|0ed58dcdb4a043718b2c6e0652992e78|concept
Indian presidency|3|event|0ed58dcdb4a043718b2c6e0652992e78|concept
multilateral investment|3|concept|0ed58dcdb4a043718b2c6e0652992e78|concept
LMICs|3|acronym|0ed58dcdb4a043718b2c6e0652992e78|concept
G20 stakeholders|3|concept|0ed58dcdb4a043718b2c6e0652992e78|concept
IHR amendments|4|concept|84f7c3515e664f558f550a928bdde5b8|concept
WHO CA+|3|organisation|84f7c3515e664f558f550a928bdde5b8|concept
Geneva|2|place|84f7c3515e664f558f550a928bdde5b8|concept
Public Health Workforce|5|concept|9788f3475aa54d1db48ff648f860e453|concept
Gender Inequality|4|concept|9788f3475aa54d1db48ff648f860e453|concept
Health Sector|3|organisation|9788f3475aa54d1db48ff648f860e453|concept
World Health Organization|4|organisation|9788f3475aa54d1db48ff648f860e453|concept
Public health and emergency workforce roadmap|3|document|9788f3475aa54d1db48ff648f860e453|concept
International Association of National Public Health Institutes (IANPHI)|3|organisation|9e0d4b33f8d34f858eb42aa765c93415|concept
ASPPH|2|organisation|9e0d4b33f8d34f858eb42aa765c93415|concept
Competency based education, Public health and emergency workforce roadmap|3|concept|9e0d4b33f8d34f858eb42aa765c93415|concept
emergencies|2|event|9e0d4b33f8d34f858eb42aa765c93415|concept
Public health|3|concept|9e0d4b33f8d34f858eb42aa765c93415|concept
One Health|5|concept|c347385c32c941ca9500d586d9b9e88e|concept
World Health Organization|3|organisation|c347385c32c941ca9500d586d9b9e88e|concept
Food and Agriculture Organization|2|organisation|c347385c32c941ca9500d586d9b9e88e|concept
United Nations Environment Programme|2|organisation|c347385c32c941ca9500d586d9b9e88e|concept
World Organisation for Animal Health|2|organisation|c347385c32c941ca9500d586d9b9e88e|concept
One Health|5|concept|2dd90976e41d4112a2f6e029eb90b1e3|concept
pandemic prevention, preparedness, and response|4|concept|2dd90976e41d4112a2f6e029eb90b1e3|concept
domestic health systems|3|object|2dd90976e41d4112a2f6e029eb90b1e3|concept
India|4|place|2dd90976e41d4112a2f6e029eb90b1e3|concept
Multisectoral inclusivity|3|concept|e2379daababe407ba77deb9138fedacf|concept
OH concept|4|concept|e2379daababe407ba77deb9138fedacf|concept
Antimicrobial Resistance (AMR)|5|condition|e2379daababe407ba77deb9138fedacf|concept
Antimicrobial Resistance (AMR)|5|concept|d33d167928ec4c02a898302812a56a09|concept
WHO|4|organisation|d33d167928ec4c02a898302812a56a09|concept
Global Public Health Threats|3|concept|d33d167928ec4c02a898302812a56a09|concept
2050|4|event|d33d167928ec4c02a898302812a56a09|concept
10 million deaths|3|condition|d33d167928ec4c02a898302812a56a09|concept
Global Economy|2|concept|d33d167928ec4c02a898302812a56a09|concept
US$11-444 million|3|misc|d33d167928ec4c02a898302812a56a09|concept
global health system|5|organisation|f5f198d153604bd3a98fa4917c114a0e|concept
drug-resistant Tuberculosis|4|condition|f5f198d153604bd3a98fa4917c114a0e|concept
HIV infections|4|condition|f5f198d153604bd3a98fa4917c114a0e|concept
artemisinin-based combination therapy-resistance|3|condition|f5f198d153604bd3a98fa4917c114a0e|concept
antileprotic drug resistance|3|condition|f5f198d153604bd3a98fa4917c114a0e|concept
zoonotic diseases|4|event|f5f198d153604bd3a98fa4917c114a0e|concept
pathogens|3|object|f5f198d153604bd3a98fa4917c114a0e|concept
animals|4|misc|f5f198d153604bd3a98fa4917c114a0e|concept
urbanisation|3|condition|f5f198d153604bd3a98fa4917c114a0e|concept
destruction of natural habitats|3|event|f5f198d153604bd3a98fa4917c114a0e|concept
illegal trade in wildlife|3|organisation|f5f198d153604bd3a98fa4917c114a0e|concept
wet markets|3|object|f5f198d153604bd3a98fa4917c114a0e|concept
zoonotic disease|5|concept|764f6457770c4826aadcd6d83adba840|concept
SARS|3|event|764f6457770c4826aadcd6d83adba840|concept
MERS|3|event|764f6457770c4826aadcd6d83adba840|concept
Ebola|3|event|764f6457770c4826aadcd6d83adba840|concept
Nipah|3|event|764f6457770c4826aadcd6d83adba840|concept
avian influenza|3|event|764f6457770c4826aadcd6d83adba840|concept
agriculture sector|4|concept|764f6457770c4826aadcd6d83adba840|concept
meat handling|3|event|764f6457770c4826aadcd6d83adba840|concept
eggs|2|object|764f6457770c4826aadcd6d83adba840|concept
dairy products|2|object|764f6457770c4826aadcd6d83adba840|concept
vegetables|2|object|764f6457770c4826aadcd6d83adba840|concept
ecological connectivity|5|concept|ceced3fafd4146ab93a56d8df2c7991f|concept
biodiversity|4|concept|ceced3fafd4146ab93a56d8df2c7991f|concept
Global Early Warning and Response System for Major Animal Diseases|4|document|ceced3fafd4146ab93a56d8df2c7991f|concept
zoonoses|3|concept|ceced3fafd4146ab93a56d8df2c7991f|concept
Global Vector Control Response (GVCR) 2017–2030|4|document|ceced3fafd4146ab93a56d8df2c7991f|concept
vector-borne diseases|3|concept|ceced3fafd4146ab93a56d8df2c7991f|concept
Accelerating Global Health|5|event|c0439552464a4e14b6ef0c4b597c1409|concept
Pathways to Health Equity for the G20|5|event|c0439552464a4e14b6ef0c4b597c1409|concept
Water-borne diseases|3|concept|c0439552464a4e14b6ef0c4b597c1409|concept
Drinking or coming in contact with contaminated water|2|misc|c0439552464a4e14b6ef0c4b597c1409|concept
Faecal-contaminated water|2|object|c0439552464a4e14b6ef0c4b597c1409|concept
Two billion people globally|3|condition|c0439552464a4e14b6ef0c4b597c1409|concept
Cholera, dysentery, typhoid and polio|2|concept|c0439552464a4e14b6ef0c4b597c1409|concept
Around 485,000 deaths every year|3|condition|c0439552464a4e14b6ef0c4b597c1409|concept
Food-borne diseases|2|concept|c0439552464a4e14b6ef0c4b597c1409|concept
Over 200 diseases|1|misc|c0439552464a4e14b6ef0c4b597c1409|concept
Chemical substances such as unpasteurised (raw) milk|1|misc|c0439552464a4e14b6ef0c4b597c1409|concept
Undercooked meat or eggs|1|misc|c0439552464a4e14b6ef0c4b597c1409|concept
Raw fruits and vegetables|1|misc|c0439552464a4e14b6ef0c4b597c1409|concept
600 million people are affected by food-borne diseases|3|condition|c0439552464a4e14b6ef0c4b597c1409|concept
420,000 die each year|2|condition|c0439552464a4e14b6ef0c4b597c1409|concept
Healthy life years lost|1|misc|c0439552464a4e14b6ef0c4b597c1409|concept
Access to adequate safe and nutritious food|2|object|c0439552464a4e14b6ef0c4b597c1409|concept
One Health’|3|event|c0439552464a4e14b6ef0c4b597c1409|concept
Operationalising ‘One Health’|3|event|c0439552464a4e14b6ef0c4b597c1409|concept
One Health|5|concept|502eb4a32dcc478381748da0c9bd7614|concept
Memorandum of Understanding (MOU)|4|event|502eb4a32dcc478381748da0c9bd7614|concept
Quadripartite Collaboration for One Health|5|organisation|502eb4a32dcc478381748da0c9bd7614|concept
One Health High-Level Expert Panel|4|misc|502eb4a32dcc478381748da0c9bd7614|concept
One Health Joint Plan of Action (2022-2026)|3|document|502eb4a32dcc478381748da0c9bd7614|concept
World Health Organisation (WHO)|4|organisation|502eb4a32dcc478381748da0c9bd7614|concept
Food and Agriculture Organisation (FAO)|4|organisation|502eb4a32dcc478381748da0c9bd7614|concept
United Nations Environment Programme (UNEP)|3|organisation|502eb4a32dcc478381748da0c9bd7614|concept
World Organisation for Animal Health (OIE)|2|organisation|502eb4a32dcc478381748da0c9bd7614|concept
policy actions|3|event|46f7a03700434a8497df7279c7a66991|concept
investment in intersectoral health governance|4|concept|46f7a03700434a8497df7279c7a66991|concept
national OH policies|3|object|46f7a03700434a8497df7279c7a66991|concept
research on OH|4|event|46f7a03700434a8497df7279c7a66991|concept
genomic surveillance and data-sharing practices|3|object|46f7a03700434a8497df7279c7a66991|concept
academic courses on OH|2|event|46f7a03700434a8497df7279c7a66991|concept
One Health|5|concept|51906241584640d99e39f60f1f346d60|concept
pandemic prevention and preparedness|4|concept|51906241584640d99e39f60f1f346d60|concept
World Bank's US$10-billion fund|3|object|51906241584640d99e39f60f1f346d60|concept
UN’s high-level meeting on pandemic prevention, preparedness, and response (September 2023)|4|event|51906241584640d99e39f60f1f346d60|concept
WHO|4|organisation|51906241584640d99e39f60f1f346d60|concept
OH approach|5|concept|fc1d9effc3a4494daf5a1c78a36bf77f|concept
Databases and knowledge-sharing resources|4|object|fc1d9effc3a4494daf5a1c78a36bf77f|concept
Best practice examples|3|misc|fc1d9effc3a4494daf5a1c78a36bf77f|concept
OH workforce|4|object|fc1d9effc3a4494daf5a1c78a36bf77f|concept
Integrated OH surveillance system|3|organisation|fc1d9effc3a4494daf5a1c78a36bf77f|concept
Routine and emergency coordination mechanisms|4|misc|fc1d9effc3a4494daf5a1c78a36bf77f|concept
Standardised framework for addressing zoonotic spillover risks|3|organisation|fc1d9effc3a4494daf5a1c78a36bf77f|concept
Urbanisation and habitat fragmentation|3|misc|fc1d9effc3a4494daf5a1c78a36bf77f|concept
Spillover risks and disease spread|4|misc|fc1d9effc3a4494daf5a1c78a36bf77f|concept
G20 countries|5|organisation|fc1d9effc3a4494daf5a1c78a36bf77f|concept
G20|5|organisation|e3ed493f83654c1a87d1f5bc648a8325|concept
One Health approach in India|4|concept|e3ed493f83654c1a87d1f5bc648a8325|concept
Office of the Principal Scientific Adviser (PSA)|3|organisation|e3ed493f83654c1a87d1f5bc648a8325|concept
integrated disease surveillance|4|concept|3abe5438d6c9449f81cb2cb913a89f17|concept
environmental surveillance systems|3|concept|3abe5438d6c9449f81cb2cb913a89f17|concept
robust outbreak investigation mechanisms|3|concept|3abe5438d6c9449f81cb2cb913a89f17|concept
OH mission|4|event|3abe5438d6c9449f81cb2cb913a89f17|concept
Targeted R&D|3|concept|3abe5438d6c9449f81cb2cb913a89f17|concept
vaccines, diagnostics, therapeutics, and other prevention tools|2|object|3abe5438d6c9449f81cb2cb913a89f17|concept
data and database integration|3|concept|3abe5438d6c9449f81cb2cb913a89f17|concept
analytics for better tracking of national-level progress and implementation at the local level|2|misc|3abe5438d6c9449f81cb2cb913a89f17|concept
streamlining regulatory and approval processes|3|concept|3abe5438d6c9449f81cb2cb913a89f17|concept
One Health Centre|2|object|3abe5438d6c9449f81cb2cb913a89f17|concept
One Health|5|concept|c1f9626d266a4b3d820e6980b6dacc08|concept
zoonoses and transboundary animal diseases|4|condition|c1f9626d266a4b3d820e6980b6dacc08|concept
2008 attempt to operationalise the OH approach for zoonotic disease control and prevention|3|event|c1f9626d266a4b3d820e6980b6dacc08|concept
zonotic policy documents|4|document|c1f9626d266a4b3d820e6980b6dacc08|concept
lack of supportive policies|3|condition|c1f9626d266a4b3d820e6980b6dacc08|concept
conflicting departmental priorities|3|condition|c1f9626d266a4b3d820e6980b6dacc08|concept
limited institutional capacities|3|condition|c1f9626d266a4b3d820e6980b6dacc08|concept
cross-sectoral collaboration on disease control|2|event|c1f9626d266a4b3d820e6980b6dacc08|concept
contextual adaptation based on the underlying sociopolitical, institutional, and cultural contexts|3|concept|c1f9626d266a4b3d820e6980b6dacc08|concept
OH approach|5|concept|a23f8844edf54ac7a6711c6983787cb1|concept
interpersonal relationships|4|concept|a23f8844edf54ac7a6711c6983787cb1|concept
veterinary workforce|3|organisation|a23f8844edf54ac7a6711c6983787cb1|concept
academic institutions|4|organisation|a23f8844edf54ac7a6711c6983787cb1|concept
local population|3|misc|a23f8844edf54ac7a6711c6983787cb1|concept
Tamil Nadu Veterinary and Animal Sciences University|3|organisation|a23f8844edf54ac7a6711c6983787cb1|concept
Tamil Nadu Dr MGR Medical University|4|organisation|a23f8844edf54ac7a6711c6983787cb1|concept
Punjab|2|place|a23f8844edf54ac7a6711c6983787cb1|concept
SARS-CoV2 vaccine trial|4|event|a23f8844edf54ac7a6711c6983787cb1|concept
outbreak investigation|3|event|a23f8844edf54ac7a6711c6983787cb1|concept
vaccine hesitancy|4|concept|a23f8844edf54ac7a6711c6983787cb1|concept
ASHAs|2|organisation|a23f8844edf54ac7a6711c6983787cb1|concept
preparedness|4|concept|36dd1d845a3147dba0c7891d5d6fb924|concept
response|3|concept|36dd1d845a3147dba0c7891d5d6fb924|concept
systems and cross-sectoral capacities|4|concept|36dd1d845a3147dba0c7891d5d6fb924|concept
inclusive and equitable multi-level workplans and strategies|3|concept|36dd1d845a3147dba0c7891d5d6fb924|concept
OH principles|4|concept|36dd1d845a3147dba0c7891d5d6fb924|concept
OH tools, technologies, and practices|3|object|36dd1d845a3147dba0c7891d5d6fb924|concept
data and knowledge|4|concept|36dd1d845a3147dba0c7891d5d6fb924|concept
Global Health|5|concept|baf822f00df24576a51d07fdc84491e6|concept
Pathways to Health Equity|4|concept|baf822f00df24576a51d07fdc84491e6|concept
G20|3|organisation|baf822f00df24576a51d07fdc84491e6|concept
Infectious diseases|4|concept|baf822f00df24576a51d07fdc84491e6|concept
Surveillance systems|3|object|baf822f00df24576a51d07fdc84491e6|concept
Global collaboration and solidarity|4|concept|baf822f00df24576a51d07fdc84491e6|concept
Nature|2|object|baf822f00df24576a51d07fdc84491e6|concept
Health and well-being for all people everywhere|4|concept|baf822f00df24576a51d07fdc84491e6|concept
MS Swaminathan Research Foundation|2|organisation|baf822f00df24576a51d07fdc84491e6|concept
World Health Organization|3|organisation|baf822f00df24576a51d07fdc84491e6|concept
Dr Soumya Swaminathan|4|person|baf822f00df24576a51d07fdc84491e6|concept
Dr Priyadarshini Rajamani|2|person|baf822f00df24576a51d07fdc84491e6|concept
Accelerating Global Health|5|event|c0a97f842ce84d1399bb35fcc9ca17a8|concept
Pathways to Health Equity for the G20|4|concept|c0a97f842ce84d1399bb35fcc9ca17a8|concept
Building a Resilient Digital Health Ecosystem in India|3|event|c0a97f842ce84d1399bb35fcc9ca17a8|concept
Lav Agarwal|2|person|c0a97f842ce84d1399bb35fcc9ca17a8|concept
technology|5|concept|c0a97f842ce84d1399bb35fcc9ca17a8|concept
communication|4|concept|c0a97f842ce84d1399bb35fcc9ca17a8|concept
transportation|3|concept|c0a97f842ce84d1399bb35fcc9ca17a8|concept
healthcare|5|concept|c0a97f842ce84d1399bb35fcc9ca17a8|concept
electronic health records|3|object|c0a97f842ce84d1399bb35fcc9ca17a8|concept
artificial intelligence|4|concept|c0a97f842ce84d1399bb35fcc9ca17a8|concept
wearable devices|3|object|c0a97f842ce84d1399bb35fcc9ca17a8|concept
health apps|2|object|c0a97f842ce84d1399bb35fcc9ca17a8|concept
research|3|concept|00596c043eb84a829a663e034eb52bde|concept
discovering new treatments|4|concept|00596c043eb84a829a663e034eb52bde|concept
improving overall healthcare outcomes|3|concept|00596c043eb84a829a663e034eb52bde|concept
COVID-19 pandemic|4|event|00596c043eb84a829a663e034eb52bde|concept
exponential growth of digital health|3|concept|00596c043eb84a829a663e034eb52bde|concept
India's massive population|4|event|a57747eedbc94f27aeaa023ebf800e32|concept
Digital Health Landscape in India|3|misc|a57747eedbc94f27aeaa023ebf800e32|concept
equitable access to healthcare services|4|event|a57747eedbc94f27aeaa023ebf800e32|concept
technology|3|misc|a57747eedbc94f27aeaa023ebf800e32|concept
digital platforms for care|4|event|a57747eedbc94f27aeaa023ebf800e32|concept
interoperable and standardised electronic health records|3|object|a57747eedbc94f27aeaa023ebf800e32|concept
Electronic Health Record standards|2|document|a57747eedbc94f27aeaa023ebf800e32|concept
National Health Policy|3|document|a57747eedbc94f27aeaa023ebf800e32|concept
India|5|place|1c7917baa4ae4cee997ec26107908884|concept
Digital healthcare|4|concept|1c7917baa4ae4cee997ec26107908884|concept
Hospital Management Information System|3|organisation|1c7917baa4ae4cee997ec26107908884|concept
Online Registration System|2|object|1c7917baa4ae4cee997ec26107908884|concept
National tuberculosis elimination (Ni-kshay)|3|organisation|1c7917baa4ae4cee997ec26107908884|concept
Mother and Child Tracking System|2|object|1c7917baa4ae4cee997ec26107908884|concept
Mera Aspataal (My Hospital)|2|organisation|1c7917baa4ae4cee997ec26107908884|concept
Health Management Information System|3|object|1c7917baa4ae4cee997ec26107908884|concept
Integrated Health Information Platform|2|organisation|1c7917baa4ae4cee997ec26107908884|concept
Non-Communicable Diseases screening application|2|object|1c7917baa4ae4cee997ec26107908884|concept
Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY)|4|event|1c7917baa4ae4cee997ec26107908884|concept
health and wellness centers|4|organisation|eba3bd7af89a46a586d2786a9549f23b|concept
preventive care|3|concept|eba3bd7af89a46a586d2786a9549f23b|concept
primary care|3|concept|eba3bd7af89a46a586d2786a9549f23b|concept
telemedicine consultation services|4|object|eba3bd7af89a46a586d2786a9549f23b|concept
Accelerating Global Health|4|event|ec1766626938432892c24b9acb2ca6ca|concept
Health Equity for the G20|4|event|ec1766626938432892c24b9acb2ca6ca|concept
financial protection of up to INR 500,000 per family annually|3|concept|ec1766626938432892c24b9acb2ca6ca|concept
over 120 million crore poor and vulnerable families|3|concept|ec1766626938432892c24b9acb2ca6ca|concept
Indian population|3|place|ec1766626938432892c24b9acb2ca6ca|concept
wellness-oriented approach|3|concept|ec1766626938432892c24b9acb2ca6ca|concept
universal health coverage (UHC)|3|concept|ec1766626938432892c24b9acb2ca6ca|concept
patient data portability|2|misc|ec1766626938432892c24b9acb2ca6ca|concept
environment where all people can obtain health services|3|concept|ec1766626938432892c24b9acb2ca6ca|concept
rethink the core technology backbone of our system|2|misc|ec1766626938432892c24b9acb2ca6ca|concept
cutting-edge digital solutions|2|concept|ec1766626938432892c24b9acb2ca6ca|concept
converge into|1|misc|ec1766626938432892c24b9acb2ca6ca|concept
Resilient Digital Health Ecosystem|5|event|784ecfb5b0fa4e41a0d142cf69671e30|concept
ABHA numbers|4|document|784ecfb5b0fa4e41a0d142cf69671e30|concept
ABDM ecosystem|4|organisation|784ecfb5b0fa4e41a0d142cf69671e30|concept
healthcare structure|3|condition|784ecfb5b0fa4e41a0d142cf69671e30|concept
COVID-19 pandemic|4|event|784ecfb5b0fa4e41a0d142cf69671e30|concept
activities|3|misc|c3bf84643ff44d68bf38a16e96fd9e86|concept
innovative solutions|4|concept|c3bf84643ff44d68bf38a16e96fd9e86|concept
continuity of health services|4|concept|c3bf84643ff44d68bf38a16e96fd9e86|concept
whole of government, whole of society' approach|3|misc|c3bf84643ff44d68bf38a16e96fd9e86|concept
pandemic battle|4|event|c3bf84643ff44d68bf38a16e96fd9e86|concept
subnational and local governments|3|organisation|c3bf84643ff44d68bf38a16e96fd9e86|concept
civil society organisations|3|organisation|c3bf84643ff44d68bf38a16e96fd9e86|concept
private sector|3|organisation|c3bf84643ff44d68bf38a16e96fd9e86|concept
local communities|3|organisation|c3bf84643ff44d68bf38a16e96fd9e86|concept
Telemedicine Practice Guidelines|4|document|c3bf84643ff44d68bf38a16e96fd9e86|concept
eSanjeevaniOPD|4|organisation|c3bf84643ff44d68bf38a16e96fd9e86|concept
world’s largest national telemedicine service|3|misc|c3bf84643ff44d68bf38a16e96fd9e86|concept
online health facilities|4|object|c3bf84643ff44d68bf38a16e96fd9e86|concept
eSanjeevani initiative|3|organisation|c3bf84643ff44d68bf38a16e96fd9e86|concept
digital divide|3|condition|c3bf84643ff44d68bf38a16e96fd9e86|concept
rural areas|2|place|c3bf84643ff44d68bf38a16e96fd9e86|concept
access to healthcare|3|condition|c3bf84643ff44d68bf38a16e96fd9e86|concept
completed 142 million|2|misc|c3bf84643ff44d68bf38a16e96fd9e86|concept
consultations|5|event|00c023acbd1649be8e5673413309c140|concept
record time|4|condition|00c023acbd1649be8e5673413309c140|concept
patients|3|object|00c023acbd1649be8e5673413309c140|concept
27 July 2023|2|misc|00c023acbd1649be8e5673413309c140|concept
abdm.gov.in|1|document|00c023acbd1649be8e5673413309c140|concept
esanjeevani.mohfw.gov.in|1|document|00c023acbd1649be8e5673413309c140|concept
Accelerating Global Health|5|concept|96c919e1d14e4ba9870d0f5015e90f1f|concept
CoWIN|4|organisation|96c919e1d14e4ba9870d0f5015e90f1f|concept
COVID-19 'war rooms'|3|object|96c919e1d14e4ba9870d0f5015e90f1f|concept
digital health initiatives|4|concept|96c919e1d14e4ba9870d0f5015e90f1f|concept
COVID-19 India Portal|3|object|96c919e1d14e4ba9870d0f5015e90f1f|concept
inventory tracking|4|event|a29a332cd2de4594a574bb57c7d10fd2|concept
Aarogya Setu|3|organisation|a29a332cd2de4594a574bb57c7d10fd2|concept
RT-PCR app|2|object|a29a332cd2de4594a574bb57c7d10fd2|concept
COVID-19 facility app|3|organisation|a29a332cd2de4594a574bb57c7d10fd2|concept
National Public Health Observatory (NPHO)|4|organisation|a29a332cd2de4594a574bb57c7d10fd2|concept
Health Emergency Operations Centre (HEOC)|3|organisation|a29a332cd2de4594a574bb57c7d10fd2|concept
overall healthcare service delivery|5|event|c53fa240102b418d96669de0302129ff|concept
integration of healthcare programmes|4|concept|c53fa240102b418d96669de0302129ff|concept
transformation of the healthcare situation in the country|5|event|c53fa240102b418d96669de0302129ff|concept
Resilient Digital Health Ecosystem|5|concept|8368e5f419c943b89a7a33939b57aa87|concept
AI in healthcare|4|event|8368e5f419c943b89a7a33939b57aa87|concept
Centres of Excellence for AI|3|place|8368e5f419c943b89a7a33939b57aa87|concept
Clinical decision support system|2|object|8368e5f419c943b89a7a33939b57aa87|concept
Event-based disease surveillance|2|event|8368e5f419c943b89a7a33939b57aa87|concept
impending disease outbreak|5|event|8ef6462971234fea8ca5b9c897badcc4|concept
AI assistant for frontline workers in 11 Indian languages|4|object|8ef6462971234fea8ca5b9c897badcc4|concept
Stimulating Advanced Knowledge for Sustainable Health Management (SAKSHAM) Portal|4|organisation|8ef6462971234fea8ca5b9c897badcc4|concept
inclusive capacity building of health professionals|3|concept|8ef6462971234fea8ca5b9c897badcc4|concept
Tele-education in medical education for remote areas|4|event|8ef6462971234fea8ca5b9c897badcc4|concept
online platforms, video conferencing, pre-recorded lectures|3|object|8ef6462971234fea8ca5b9c897badcc4|concept
government unified and dedicated online learning and training platform SAKSHAM|4|organisation|8ef6462971234fea8ca5b9c897badcc4|concept
health professionals|4|organisation|9b1e7fd4829c450b8cc36fbd9453d186|concept
advanced training|3|event|9b1e7fd4829c450b8cc36fbd9453d186|concept
regular jobs|2|condition|9b1e7fd4829c450b8cc36fbd9453d186|concept
portal|3|object|9b1e7fd4829c450b8cc36fbd9453d186|concept
public health|2|concept|9b1e7fd4829c450b8cc36fbd9453d186|concept
clinical practices|2|event|9b1e7fd4829c450b8cc36fbd9453d186|concept
Accelerating Global Health|4|event|a4cd493a8ff94f7b9f31d65bd15833b2|concept
Pathways to Health Equity for the G20|3|concept|a4cd493a8ff94f7b9f31d65bd15833b2|concept
Digital health|4|object|a4cd493a8ff94f7b9f31d65bd15833b2|concept
Public sector|3|organisation|a4cd493a8ff94f7b9f31d65bd15833b2|concept
Private sector|3|organisation|a4cd493a8ff94f7b9f31d65bd15833b2|concept
National digital health ecosystem|4|object|a4cd493a8ff94f7b9f31d65bd15833b2|concept
Digital tools|3|object|a4cd493a8ff94f7b9f31d65bd15833b2|concept
World Health Assembly|4|event|a4cd493a8ff94f7b9f31d65bd15833b2|concept
World Health Organization (WHO)|5|organisation|71de2efb72064d318b9e0bee887f6879|concept
Global Digital Health Partnership (GDHP)|4|organisation|71de2efb72064d318b9e0bee887f6879|concept
Department for Digital Health and Innovation|3|organisation|71de2efb72064d318b9e0bee887f6879|concept
Global Strategy on Digital Health 2020-2025|3|document|71de2efb72064d318b9e0bee887f6879|concept
India's G20 Leadership|5|event|eb215b2863164d6ba5e98fcffff46cba|concept
Global Health Initiatives|4|concept|eb215b2863164d6ba5e98fcffff46cba|concept
Climate Change|3|concept|eb215b2863164d6ba5e98fcffff46cba|concept
Food Insecurity|2|condition|eb215b2863164d6ba5e98fcffff46cba|concept
pandemic|5|event|1a76e52834584b208c08bddb9a1f0b62|concept
international cooperation|4|organisation|1a76e52834584b208c08bddb9a1f0b62|concept
health emergency|4|event|1a76e52834584b208c08bddb9a1f0b62|concept
One Health|3|concept|1a76e52834584b208c08bddb9a1f0b62|concept
antimicrobial resistance|3|condition|1a76e52834584b208c08bddb9a1f0b62|concept
pharmaceutical sector|3|organisation|1a76e52834584b208c08bddb9a1f0b62|concept
vaccines, therapeutics, diagnostics|2|object|1a76e52834584b208c08bddb9a1f0b62|concept
Digital Health|5|concept|998d8f77c3c949cd8843d7bdf421b78d|concept
India's G20 presidency|4|event|998d8f77c3c949cd8843d7bdf421b78d|concept
Global Initiative on Digital Health (GIDH)|3|organisation|998d8f77c3c949cd8843d7bdf421b78d|concept
World Health Organization (WHO)|2|organisation|998d8f77c3c949cd8843d7bdf421b78d|concept
digital public goods|5|concept|73e23711e0a54a8dafa05eb4e0949f6b|concept
WHO norms, standards, and|4|organisation|73e23711e0a54a8dafa05eb4e0949f6b|concept
Accelerating Global Health|4|event|97cddb2fd5c54f7f91c34ca00913ee2e|concept
Pathways to Health Equity for the G20|4|event|97cddb2fd5c54f7f91c34ca00913ee2e|concept
digital transformation|3|concept|97cddb2fd5c54f7f91c34ca00913ee2e|concept
ABDM|2|organisation|97cddb2fd5c54f7f91c34ca00913ee2e|concept
CoWIN|2|organisation|97cddb2fd5c54f7f91c34ca00913ee2e|concept
eSanjeevani|2|object|97cddb2fd5c54f7f91c34ca00913ee2e|concept
Lav Agarwal|4|person|ebc08425c0f94baaad5796ba621470b9|concept
eHealth|3|organisation|ebc08425c0f94baaad5796ba621470b9|concept
International Health & Collaboration|2|concept|ebc08425c0f94baaad5796ba621470b9|concept
Public Health|3|concept|ebc08425c0f94baaad5796ba621470b9|concept
G20|2|organisation|ebc08425c0f94baaad5796ba621470b9|concept
India's Digital Public Infrastructure Transformation|5|event|9b7a9f8531134be2b16e734bda64a349|concept
Digital India programme|4|document|9b7a9f8531134be2b16e734bda64a349|concept
India Enterprise Architecture|5|concept|508c60a74e3c4391a8d4136d0a90ffeb|concept
Ministry of Electronics and Information Technology (MeitY)|4|organisation|508c60a74e3c4391a8d4136d0a90ffeb|concept
One Government|3|concept|508c60a74e3c4391a8d4136d0a90ffeb|concept
Data Empowerment and Protection Architecture (DEPA)|2|organisation|508c60a74e3c4391a8d4136d0a90ffeb|concept
framework|3|event|b7f8f25fdd3c482cb13517142b7c0117|concept
DEPA|4|concept|b7f8f25fdd3c482cb13517142b7c0117|concept
consent-governed and secure data-sharing|3|event|b7f8f25fdd3c482cb13517142b7c0117|concept
controlled by consent managers|2|concept|b7f8f25fdd3c482cb13517142b7c0117|concept
private ecosystem|3|event|b7f8f25fdd3c482cb13517142b7c0117|concept
citizens|2|organisation|b7f8f25fdd3c482cb13517142b7c0117|concept
finance sector|3|event|b7f8f25fdd3c482cb13517142b7c0117|concept
loans, insurance, and other financial products|2|event|b7f8f25fdd3c482cb13517142b7c0117|concept
digital|1|misc|b7f8f25fdd3c482cb13517142b7c0117|concept
India Stack|5|organisation|be5f478737c04472bffaf880bf0be06b|concept
DEPA|4|organisation|be5f478737c04472bffaf880bf0be06b|concept
Aadhaar-based e-KYC|3|technology|be5f478737c04472bffaf880bf0be06b|concept
Unified Payments Interface (UPI)|4|technology|be5f478737c04472bffaf880bf0be06b|concept
Aadhaar-based eSign|3|technology|be5f478737c04472bffaf880bf0be06b|concept
Open Credit Enablement Network|2|technology|be5f478737c04472bffaf880bf0be06b|concept
Digital infrastructure|4|concept|be5f478737c04472bffaf880bf0be06b|concept
Private sector service delivery|3|concept|be5f478737c04472bffaf880bf0be06b|concept
digital transactions|4|event|6c3a8512b9a140c983b92ad7f3e5ac41|concept
November 2019|3|time|6c3a8512b9a140c983b92ad7f3e5ac41|concept
January 2023|3|time|6c3a8512b9a140c983b92ad7f3e5ac41|concept
India's Digital Public Infrastructure Transformation|5|event|26dcc67d7f7c43b4a92343aa220232c4|concept
MeitY study|4|document|26dcc67d7f7c43b4a92343aa220232c4|concept
US$500 billion by 2025|3|condition|26dcc67d7f7c43b4a92343aa220232c4|concept
India's digital economy potential to US$1 trillion|4|concept|26dcc67d7f7c43b4a92343aa220232c4|concept
business as usual scenario|2|misc|26dcc67d7f7c43b4a92343aa220232c4|concept
real-time payments in India, China, Brazil|3|concept|26dcc67d7f7c43b4a92343aa220232c4|concept
Direct Benefit Transfer (DBT) programme|4|organisation|26dcc67d7f7c43b4a92343aa220232c4|concept
physical delivery of financial benefits|2|misc|26dcc67d7f7c43b4a92343aa220232c4|concept
digital payment systems|3|object|26dcc67d7f7c43b4a92343aa220232c4|concept
beneficiaries' bank accounts|2|organisation|26dcc67d7f7c43b4a92343aa220232c4|concept
corruption, eliminating middlemen|3|misc|26dcc67d7f7c43b4a92343aa220232c4|concept
transparency|5|concept|5e5cf5cf4f2f42189004a55fd0fbe71f|concept
direct benefit transfer (DBT) in India|4|event|5e5cf5cf4f2f42189004a55fd0fbe71f|concept
Pradhan Mantri Jan-Dhan Yojana|3|object|5e5cf5cf4f2f42189004a55fd0fbe71f|concept
Jan Dhan-Aadhaar-Mobile Yojana|4|organisation|5e5cf5cf4f2f42189004a55fd0fbe71f|concept
Indian Rupees (INR)|2|object|5e5cf5cf4f2f42189004a55fd0fbe71f|concept
FY 2021-22|3|event|5e5cf5cf4f2f42189004a55fd0fbe71f|concept
Digital India|4|organisation|5e5cf5cf4f2f42189004a55fd0fbe71f|concept
e-governance platforms|3|object|5e5cf5cf4f2f42189004a55fd0fbe71f|concept
MyGov platform|5|organisation|89d34f6b4a1149da8434c3dc7e361947|concept
digital governance|4|concept|89d34f6b4a1149da8434c3dc7e361947|concept
citizen-centricity|4|concept|89d34f6b4a1149da8434c3dc7e361947|concept
technology|4|object|89d34f6b4a1149da8434c3dc7e361947|concept
government interactions|3|concept|89d34f6b4a1149da8434c3dc7e361947|concept
citizen-government gap|3|condition|89d34f6b4a1149da8434c3dc7e361947|concept
enhance government services|3|concept|89d34f6b4a1149da8434c3dc7e361947|concept
transparency|3|condition|89d34f6b4a1149da8434c3dc7e361947|concept
democratic participation|3|concept|89d34f6b4a1149da8434c3dc7e361947|concept
digital literacy|5|concept|e5168689a0894a83821de56e5646e40c|concept
digital divide|4|condition|e5168689a0894a83821de56e5646e40c|concept
DPI|5|document|e5168689a0894a83821de56e5646e40c|concept
India's digital transformation|4|event|e5168689a0894a83821de56e5646e40c|concept
technology|3|concept|e5168689a0894a83821de56e5646e40c|concept
inclusivity|4|condition|e5168689a0894a83821de56e5646e40c|concept
scalability|3|condition|e5168689a0894a83821de56e5646e40c|concept
regulation|3|condition|e5168689a0894a83821de56e5646e40c|concept
collaboration|3|concept|e5168689a0894a83821de56e5646e40c|concept
India's Digital Public Infrastructure Transformation Ecosystem|5|event|ded53e412e15418db0ce8e093a0b0bb7|concept
government agencies|4|organisation|ded53e412e15418db0ce8e093a0b0bb7|concept
industry leaders|4|organisation|ded53e412e15418db0ce8e093a0b0bb7|concept
startups|3|organisation|ded53e412e15418db0ce8e093a0b0bb7|concept
academia|2|organisation|ded53e412e15418db0ce8e093a0b0bb7|concept
civil society organisations|3|organisation|ded53e412e15418db0ce8e093a0b0bb7|concept
India’s G20 presidency|4|event|ded53e412e15418db0ce8e093a0b0bb7|concept
Global DPI Summit21|3|event|ded53e412e15418db0ce8e093a0b0bb7|concept
Accelerating Global Health|5|event|c1ec1f16dbb64a0d8dbd9b266609afae|concept
Pathways to Health Equity for the G20|5|event|c1ec1f16dbb64a0d8dbd9b266609afae|concept
marginalised communities|4|condition|c1ec1f16dbb64a0d8dbd9b266609afae|concept
India|5|organisation|c1ec1f16dbb64a0d8dbd9b266609afae|concept
digital inclusion|3|condition|c1ec1f16dbb64a0d8dbd9b266609afae|concept
urban telephone subscribers|2|organisation|c1ec1f16dbb64a0d8dbd9b266609afae|concept
gender gap in mobile ownership|3|condition|c1ec1f16dbb64a0d8dbd9b266609afae|concept
India's digital infrastructure|4|organisation|c1ec1f16dbb64a0d8dbd9b266609afae|concept
intermediaries (digital media, e-commerce)|2|object|c1ec1f16dbb64a0d8dbd9b266609afae|concept
connectivity to cause harm or commit crimes|3|event|c1ec1f16dbb64a0d8dbd9b266609afae|concept
comprehensive measures|4|event|c1ec1f16dbb64a0d8dbd9b266609afae|concept
potential DPI’s scalability|2|object|c1ec1f16dbb64a0d8dbd9b266609afae|concept
regulatory sandboxes|4|concept|717cc8137f1e405aa98adda0a4d527db|concept
innovative technologies|3|concept|717cc8137f1e405aa98adda0a4d527db|concept
consumer protection|4|condition|717cc8137f1e405aa98adda0a4d527db|concept
risk mitigation|3|condition|717cc8137f1e405aa98adda0a4d527db|concept
India's Digital Public Infrastructure Transformation|5|event|3dea693354c2490488cf797844863da1|concept
forums and platforms for stakeholders|4|object|3dea693354c2490488cf797844863da1|concept
policy discussions and regulatory consultations|4|event|3dea693354c2490488cf797844863da1|concept
balanced regulatory policies|3|concept|3dea693354c2490488cf797844863da1|concept
Indian regulators|4|organisation|3dea693354c2490488cf797844863da1|concept
Digital Personal Data Protection Bill 2022|3|document|3dea693354c2490488cf797844863da1|concept
presentation of the Digital India Act 2023|3|event|3dea693354c2490488cf797844863da1|concept
consumer needs, emerging technologies, and market trends|4|condition|3dea693354c2490488cf797844863da1|concept
challenges|2|misc|3dea693354c2490488cf797844863da1|concept
technology|5|concept|2d915595100243ee97337357adfbd5a8|concept
regulatory frameworks|4|concept|2d915595100243ee97337357adfbd5a8|concept
India's DPI|4|concept|2d915595100243ee97337357adfbd5a8|concept
Aadhaar|3|object|2d915595100243ee97337357adfbd5a8|concept
UPI|3|object|2d915595100243ee97337357adfbd5a8|concept
digital health infrastructure|3|object|2d915595100243ee97337357adfbd5a8|concept
DBT|3|object|2d915595100243ee97337357adfbd5a8|concept
e-governance|3|object|2d915595100243ee97337357adfbd5a8|concept
Accelerating Global Health|5|event|613d6988832246eaaf57f6d9192e54d0|concept
Pathways to Health Equity for the G20|4|concept|613d6988832246eaaf57f6d9192e54d0|concept
India's DPI experience|3|object|613d6988832246eaaf57f6d9192e54d0|concept
Digital systems|3|object|613d6988832246eaaf57f6d9192e54d0|concept
Inclusive societies|2|concept|613d6988832246eaaf57f6d9192e54d0|concept
Sustainable development in the 21st century|2|event|613d6988832246eaaf57f6d9192e54d0|concept
Sameer Kanwar|3|person|613d6988832246eaaf57f6d9192e54d0|concept
Varun Kumar|2|person|613d6988832246eaaf57f6d9192e54d0|concept
Antibiotics|5|object|a2e40d44ac8b4bc1b87b168a9a450207|concept
Antimicrobial Resistance (AMR)|5|concept|a2e40d44ac8b4bc1b87b168a9a450207|concept
Global Health Crisis|4|concept|a2e40d44ac8b4bc1b87b168a9a450207|concept
Health Equity|3|concept|a2e40d44ac8b4bc1b87b168a9a450207|concept
Global Economy|2|object|a2e40d44ac8b4bc1b87b168a9a450207|concept
Extreme Poverty|1|condition|a2e40d44ac8b4bc1b87b168a9a450207|concept
Developing Nations|2|location|a2e40d44ac8b4bc1b87b168a9a450207|concept
AMR|5|concept|845384860a874fc8b18ed38b165d91fb|concept
Interventions|3|concept|845384860a874fc8b18ed38b165d91fb|concept
Antimicrobials|4|object|845384860a874fc8b18ed38b165d91fb|concept
Healthcare Systems|3|place|845384860a874fc8b18ed38b165d91fb|concept
Patient Outcomes|4|concept|845384860a874fc8b18ed38b165d91fb|concept
Health Equity|3|condition|845384860a874fc8b18ed38b165d91fb|concept
Essay|2|document|845384860a874fc8b18ed38b165d91fb|concept
Ranga Reddy Burri|1|person|845384860a874fc8b18ed38b165d91fb|concept
Robert Skov|1|person|845384860a874fc8b18ed38b165d91fb|concept
Bulagonda Eswarappa Pradeep|1|person|845384860a874fc8b18ed38b165d91fb|concept
Ralf Sudbrak|1|person|845384860a874fc8b18ed38b165d91fb|concept
Antimicrobial Resistance|5|concept|f1e59f2d24db4d059c8bc8fdc7a5193c|concept
Persistent Infectious Diseases|4|condition|f1e59f2d24db4d059c8bc8fdc7a5193c|concept
Antimicrobial Drugs|3|object|f1e59f2d24db4d059c8bc8fdc7a5193c|concept
Biological Evolution|4|concept|f1e59f2d24db4d059c8bc8fdc7a5193c|concept
Defense System of Microorganisms|3|condition|f1e59f2d24db4d059c8bc8fdc7a5193c|concept
Antibiotic Resistance Mechanisms|4|concept|f1e59f2d24db4d059c8bc8fdc7a5193c|concept
Antimicrobial Resistance (AMR)|5|concept|5f12a23a8cd14c22a6ce2a6851934d50|concept
Resistance|4|condition|5f12a23a8cd14c22a6ce2a6851934d50|concept
Antibiotics|3|object|5f12a23a8cd14c22a6ce2a6851934d50|concept
Microorganisms|2|concept|5f12a23a8cd14c22a6ce2a6851934d50|concept
Selection|4|condition|5f12a23a8cd14c22a6ce2a6851934d50|concept
Accelerating Global Health|5|event|66c6d834348b4a62b864b5a39bb15fe1|concept
Pathways to Health Equity for the G20|4|concept|66c6d834348b4a62b864b5a39bb15fe1|concept
Inadequate infection prevention and control|4|condition|66c6d834348b4a62b864b5a39bb15fe1|concept
AMR|3|concept|66c6d834348b4a62b864b5a39bb15fe1|concept
Hand hygiene|2|condition|66c6d834348b4a62b864b5a39bb15fe1|concept
Improper disinfection and sterilisation practices|2|condition|66c6d834348b4a62b864b5a39bb15fe1|concept
Inadequate sanitation|2|condition|66c6d834348b4a62b864b5a39bb15fe1|concept
Hospital-acquired infections|2|condition|66c6d834348b4a62b864b5a39bb15fe1|concept
Infection prevention and control measures|3|concept|66c6d834348b4a62b864b5a39bb15fe1|concept
Infection control practices|2|condition|66c6d834348b4a62b864b5a39bb15fe1|concept
Low- and middle-income countries (LMICs)|3|condition|66c6d834348b4a62b864b5a39bb15fe1|concept
World Health Organization|2|organisation|66c6d834348b4a62b864b5a39bb15fe1|concept
WHO|4|organisation|814076eb4141455baa4afe3bddce0dd9|concept
US Centers for Disease Control and Prevention|3|organisation|814076eb4141455baa4afe3bddce0dd9|concept
Infection Control Academy of India (IFCAI)|2|organisation|814076eb4141455baa4afe3bddce0dd9|concept
Abuse/inappropriate use of antibiotics|3|condition|814076eb4141455baa4afe3bddce0dd9|concept
Selection pressure on microbes due to the use of antimicrobial drugs|3|condition|814076eb4141455baa4afe3bddce0dd9|concept
Social and administrative factors|2|condition|814076eb4141455baa4afe3bddce0dd9|concept
Availability of antimicrobials through over-the-counter (OTC) sales without requiring prescriptions|3|condition|814076eb4141455baa4afe3bddce0dd9|concept
Inappropriate prescription of antibiotics by physicians|2|condition|814076eb4141455baa4afe3bddce0dd9|concept
Study conducted by WHO|2|event|814076eb4141455baa4afe3bddce0dd9|concept
Significant proportion of antimicrobials prescribed in outpatient departments were unnecessary or inappropriate|3|condition|814076eb4141455baa4afe3bddce0dd9|concept
Rampant use of antibiotics in the livestock sector|2|condition|814076eb4141455baa4afe3bddce0dd9|concept
antibiotic|5|object|0aef0d4620f242e996cf1d0b2d84b4cc|concept
patients|3|organisation|0aef0d4620f242e996cf1d0b2d84b4cc|concept
OTC sale of antimicrobials|4|event|0aef0d4620f242e996cf1d0b2d84b4cc|concept
New legislation|3|event|0aef0d4620f242e996cf1d0b2d84b4cc|concept
stricter antibiotic prescription and consumption measures|4|event|0aef0d4620f242e996cf1d0b2d84b4cc|concept
antimicrobial drug development process|3|concept|0aef0d4620f242e996cf1d0b2d84b4cc|concept
advancements in computational|2|misc|0aef0d4620f242e996cf1d0b2d84b4cc|concept
Battle Against Antimicrobial Resistance|5|event|7fb1b39b4037448eaf3eb30e1898fc7e|concept
chemistry and artificial intelligence (AI)|4|concept|7fb1b39b4037448eaf3eb30e1898fc7e|concept
antimicrobials|3|object|7fb1b39b4037448eaf3eb30e1898fc7e|concept
in vitro and in vivo trials|2|event|7fb1b39b4037448eaf3eb30e1898fc7e|concept
bacteria|3|organisation|7fb1b39b4037448eaf3eb30e1898fc7e|concept
antibiotics|4|object|7fb1b39b4037448eaf3eb30e1898fc7e|concept
quicker and more efficient antibiotic testing and approval pipelines|3|event|7fb1b39b4037448eaf3eb30e1898fc7e|concept
antimicrobial discovery|4|concept|7fb1b39b4037448eaf3eb30e1898fc7e|concept
existing drugs|3|object|7fb1b39b4037448eaf3eb30e1898fc7e|concept
natural products|2|organisation|7fb1b39b4037448eaf3eb30e1898fc7e|concept
alternate treatment strategies|2|concept|7fb1b39b4037448eaf3eb30e1898fc7e|concept
computational approaches for drug design|3|concept|7fb1b39b4037448eaf3eb30e1898fc7e|concept
interdisciplinary collaborations|2|event|7fb1b39b4037448eaf3eb30e1898fc7e|concept
new technologies|2|organisation|7fb1b39b4037448eaf3eb30e1898fc7e|concept
clinical antibacterial pipeline|3|object|7fb1b39b4037448eaf3eb30e1898fc7e|concept
AMR infections|4|condition|c00efcf689b046e79324603ecf4f180e|concept
antibacterials|4|object|c00efcf689b046e79324603ecf4f180e|concept
WHO priority pathogens|3|concept|c00efcf689b046e79324603ecf4f180e|concept
tuberculosis|2|condition|c00efcf689b046e79324603ecf4f180e|concept
Global AMR R&D Hub|3|organisation|c00efcf689b046e79324603ecf4f180e|concept
WHO|4|organisation|c00efcf689b046e79324603ecf4f180e|concept
development of new antibacterial treatments|5|concept|676eaa0f093b4fbc80687cb2f30c6f16|concept
emerging threat of AMR|4|condition|676eaa0f093b4fbc80687cb2f30c6f16|concept
return on investment for new antibiotics|3|concept|676eaa0f093b4fbc80687cb2f30c6f16|concept
big pharmaceutical companies|2|organisation|676eaa0f093b4fbc80687cb2f30c6f16|concept
antibiotic market|3|market|676eaa0f093b4fbc80687cb2f30c6f16|concept
small or micro biotech firms|2|organisation|676eaa0f093b4fbc80687cb2f30c6f16|concept
novel reimbursement models|3|misc|676eaa0f093b4fbc80687cb2f30c6f16|concept
Accelerating Global Health|4|event|29773bc63cdc4fa680e82c66e6629eed|concept
Pathways to Health Equity for the G20|3|concept|29773bc63cdc4fa680e82c66e6629eed|concept
Innovative financing mechanisms|5|concept|29773bc63cdc4fa680e82c66e6629eed|concept
Antimicrobials|4|object|29773bc63cdc4fa680e82c66e6629eed|concept
Advance market commitment–type investments|3|concept|29773bc63cdc4fa680e82c66e6629eed|concept
DNDi (Drugs for Neglected Diseases Initiative)|4|organisation|29773bc63cdc4fa680e82c66e6629eed|concept
CEPI (Coalition for Epidemic Preparedness Innovations)|3|organisation|29773bc63cdc4fa680e82c66e6629eed|concept
Gavi (Global Alliance for Vaccines and Immunization)|3|organisation|29773bc63cdc4fa680e82c66e6629eed|concept
Antibiotics|4|object|29773bc63cdc4fa680e82c66e6629eed|concept
Governments pool funding|3|event|29773bc63cdc4fa680e82c66e6629eed|concept
Manufacturers and the private sector|4|organisation|29773bc63cdc4fa680e82c66e6629eed|concept
Financial incentives|3|concept|29773bc63cdc4fa680e82c66e6629eed|concept
Equitable pricing and access|4|condition|29773bc63cdc4fa680e82c66e6629eed|concept
Fight against AMR|3|event|29773bc63cdc4fa680e82c66e6629eed|concept
Effective treatments for all|4|condition|29773bc63cdc4fa680e82c66e6629eed|concept
Poor diagnostic capacity|3|condition|29773bc63cdc4fa680e82c66e6629eed|concept
Accurate and timely diagnostics|4|condition|29773bc63cdc4fa680e82c66e6629eed|concept
infectious diseases|5|concept|7745a8bcb0d44d66ad78c6d2c0971a61|concept
diagnostic capacity|4|concept|7745a8bcb0d44d66ad78c6d2c0971a61|concept
developing countries|3|place|7745a8bcb0d44d66ad78c6d2c0971a61|concept
vulnerable populations|3|misc|7745a8bcb0d44d66ad78c6d2c0971a61|concept
high-income countries|2|place|7745a8bcb0d44d66ad78c6d2c0971a61|concept
LMICs|3|organisation|7745a8bcb0d44d66ad78c6d2c0971a61|concept
quality and efficiency|2|misc|7745a8bcb0d44d66ad78c6d2c0971a61|concept
healthcare delivery|3|event|705bfb5bc30d4ce9a762f127476a6352|concept
global health goals|4|concept|705bfb5bc30d4ce9a762f127476a6352|concept
communicable diseases|3|condition|705bfb5bc30d4ce9a762f127476a6352|concept
non-communicable diseases|3|condition|705bfb5bc30d4ce9a762f127476a6352|concept
innovations related to AMR|4|event|705bfb5bc30d4ce9a762f127476a6352|concept
alternative therapies|2|concept|705bfb5bc30d4ce9a762f127476a6352|concept
bacteriophages|3|object|705bfb5bc30d4ce9a762f127476a6352|concept
antimicrobial peptides (AMPs) or bacteria|2|organisation|705bfb5bc30d4ce9a762f127476a6352|concept
antimicrobial adjuvants|3|object|705bfb5bc30d4ce9a762f127476a6352|concept
faecal microbiota transplant (FMT)|2|organisation|705bfb5bc30d4ce9a762f127476a6352|concept
competitive exclusion of pathogens|3|concept|705bfb5bc30d4ce9a762f127476a6352|concept
genetically modified probiotics|2|object|705bfb5bc30d4ce9a762f127476a6352|concept
Battle Against Antimicrobial Resistance|4|concept|573672aab4184bd0a0d749d328280bc8|concept
postbiotics|3|object|573672aab4184bd0a0d749d328280bc8|concept
antimicrobials|4|concept|573672aab4184bd0a0d749d328280bc8|concept
streamlined approval|3|misc|573672aab4184bd0a0d749d328280bc8|concept
regulatory agencies|2|organisation|573672aab4184bd0a0d749d328280bc8|concept
researchers|2|misc|573672aab4184bd0a0d749d328280bc8|concept
industry stakeholders|2|misc|573672aab4184bd0a0d749d328280bc8|concept
adaptive dose-ranging studies|3|document|573672aab4184bd0a0d749d328280bc8|concept
seamless phase transitions|2|misc|573672aab4184bd0a0d749d328280bc8|concept
drug repurposing|3|concept|573672aab4184bd0a0d749d328280bc8|concept
Approved drugs|3|object|a2dff2067d5543578a60182bfd8845c5|concept
Preclinical and early clinical development stages|2|event|a2dff2067d5543578a60182bfd8845c5|concept
Repurposing drugs|4|concept|a2dff2067d5543578a60182bfd8845c5|concept
In-silico analyses|3|event|a2dff2067d5543578a60182bfd8845c5|concept
High-throughput screening|3|event|a2dff2067d5543578a60182bfd8845c5|concept
Drug libraries|2|object|a2dff2067d5543578a60182bfd8845c5|concept
Antibacterial activity|3|concept|a2dff2067d5543578a60182bfd8845c5|concept
Machine learning (ML)|4|technique|a2dff2067d5543578a60182bfd8845c5|concept
Artificial intelligence (AI)|4|technique|a2dff2067d5543578a60182bfd8845c5|concept
Neural network-based approaches|3|event|a2dff2067d5543578a60182bfd8845c5|concept
Molecular fingerprints|2|object|a2dff2067d5543578a60182bfd8845c5|concept
Diagnostic process|3|event|a2dff2067d5543578a60182bfd8845c5|concept
Industry Collaboration|4|event|21cf6462eb7f41de8afc3c403e296587|concept
Sri Sathya Sai Institute of Higher Learning|2|organization|21cf6462eb7f41de8afc3c403e296587|concept
IFCAI|2|organization|21cf6462eb7f41de8afc3c403e296587|concept
SCIINV Biosciences Private Limited|2|organization|21cf6462eb7f41de8afc3c403e296587|concept
AMRx™|3|object|21cf6462eb7f41de8afc3c403e296587|concept
AI/ML-based culture-free prediction system|4|concept|21cf6462eb7f41de8afc3c403e296587|concept
Urinary Tract Infections|3|condition|21cf6462eb7f41de8afc3c403e296587|concept
Clinical Decision Support System|2|object|21cf6462eb7f41de8afc3c403e296587|concept
Empirical Antibiotic Prescriptions|3|concept|21cf6462eb7f41de8afc3c403e296587|concept
Unnecessary Laboratory Testing of Samples|2|condition|21cf6462eb7f41de8afc3c403e296587|concept
Accelerating Global Health|5|event|0cac054347174785b04ddef8537bee36|concept
Pathways to Health Equity for the G20|4|event|0cac054347174785b04ddef8537bee36|concept
AMR (Antimicrobial Resistance)|5|concept|0cac054347174785b04ddef8537bee36|concept
Quadripartite|3|organisation|0cac054347174785b04ddef8537bee36|concept
One Health approach|4|concept|0cac054347174785b04ddef8537bee36|concept
National Action Plans (NAPs)|3|document|0cac054347174785b04ddef8537bee36|concept
market failure for antimicrobials|4|condition|6fa033fa9795403f88f1b4cea6fa05f4|concept
financing development of novel antimicrobials|3|event|6fa033fa9795403f88f1b4cea6fa05f4|concept
Rapid Diagnostic Tests and Point-of-Care Technologies in AMR|4|concept|6fa033fa9795403f88f1b4cea6fa05f4|concept
Absolute, concrete, and timely diagnosis detection|3|event|6fa033fa9795403f88f1b4cea6fa05f4|concept
infection-causing pathogens|4|concept|6fa033fa9795403f88f1b4cea6fa05f4|concept
Rapid diagnostic tests (RDTs)|3|object|6fa033fa9795403f88f1b4cea6fa05f4|concept
Point-of-care technologies (POC)|3|object|6fa033fa9795403f88f1b4cea6fa05f4|concept
polymerase chain reaction-based tests|2|object|6fa033fa9795403f88f1b4cea6fa05f4|concept
genotypic assays|2|object|6fa033fa9795403f88f1b4cea6fa05f4|concept
phenotypic assays|2|object|6fa033fa9795403f88f1b4cea6fa05f4|concept
Battle Against Antimicrobial Resistance|5|event|132097da86644b35b8147fcb94ab68d8|concept
Accelerating Efforts to Combat AMR|3|event|132097da86644b35b8147fcb94ab68d8|concept
Combating AMR|5|concept|132097da86644b35b8147fcb94ab68d8|concept
Policy|3|object|132097da86644b35b8147fcb94ab68d8|concept
Implementation|3|event|132097da86644b35b8147fcb94ab68d8|concept
New antibiotics|4|object|132097da86644b35b8147fcb94ab68d8|concept
Alternative treatments|3|object|132097da86644b35b8147fcb94ab68d8|concept
Bacteriophages|2|organisation|132097da86644b35b8147fcb94ab68d8|concept
Infection prevention and control practices|3|object|132097da86644b35b8147fcb94ab68d8|concept
Antimicrobial use|2|condition|132097da86644b35b8147fcb94ab68d8|concept
Surveillance and data collection|3|event|132097da86644b35b8147fcb94ab68d8|concept
One Health approach|2|organisation|132097da86644b35b8147fcb94ab68d8|concept
National and global health plans|3|document|132097da86644b35b8147fcb94ab68d8|concept
Stakeholders|2|organisation|132097da86644b35b8147fcb94ab68d8|concept
Political will|2|event|132097da86644b35b8147fcb94ab68d8|concept
Accelerating Global Health|5|event|83a561974e644530b643bd7b78aaca7a|concept
Pathways to Health Equity for the G20|5|event|83a561974e644530b643bd7b78aaca7a|concept
AMR|5|concept|83a561974e644530b643bd7b78aaca7a|concept
LMICs|4|condition|83a561974e644530b643bd7b78aaca7a|concept
vulnerable populations in HICs|4|condition|83a561974e644530b643bd7b78aaca7a|concept
antimicrobials pipeline|3|concept|83a561974e644530b643bd7b78aaca7a|concept
industry leaving the field of antimicrobial drug discovery|4|event|83a561974e644530b643bd7b78aaca7a|concept
AMR pandemic|5|concept|83a561974e644530b643bd7b78aaca7a|concept
consequences of AMR|4|event|83a561974e644530b643bd7b78aaca7a|concept
need for increased action|5|event|83a561974e644530b643bd7b78aaca7a|concept
multifaceted effort|4|event|83a561974e644530b643bd7b78aaca7a|concept
reducing the circulation and spread of existing resistant microorganisms|3|event|83a561974e644530b643bd7b78aaca7a|concept
increase of novel resistance mechanisms|4|concept|83a561974e644530b643bd7b78aaca7a|concept
lowering the overall use of antimicrobials|3|event|83a561974e644530b643bd7b78aaca7a|concept
antimicrobial stewardship|4|concept|83a561974e644530b643bd7b78aaca7a|concept
accessibility of affordable and timely diagnostics|3|event|83a561974e644530b643bd7b78aaca7a|concept
strengthening IPC and biosecurity procedures|3|event|83a561974e644530b643bd7b78aaca7a|concept
Dr. Bulagonda Eswarappa Pradeep|2|person|6c480a85100e4e80adba9687a25de868|concept
Department of Biosciences|3|organisation|6c480a85100e4e80adba9687a25de868|concept
Sri Sathya Sai Institute of Higher Learning|2|organisation|6c480a85100e4e80adba9687a25de868|concept
India|3|place|6c480a85100e4e80adba9687a25de868|concept
Dr. Ralf Sudbrak|2|person|6c480a85100e4e80adba9687a25de868|concept
Deputy Director at the Global A M R R & D Hub|3|organisation|6c480a85100e4e80adba9687a25de868|concept
Berlin, Germany|2|place|6c480a85100e4e80adba9687a25de868|concept
G20 Countries|5|organisation|47b323d77856431b8d67d73bf0cde810|concept
Average Life Expectancy|4|condition|47b323d77856431b8d67d73bf0cde810|concept
Global Average of Life Expectancy|3|condition|47b323d77856431b8d67d73bf0cde810|concept
Accelerating Global Health|4|concept|ec5c38d181dd4fe98b66c735aac3841b|concept
G20|5|organisation|ec5c38d181dd4fe98b66c735aac3841b|concept
Public Health Outcomes|4|concept|ec5c38d181dd4fe98b66c735aac3841b|concept
Health Equity|4|concept|ec5c38d181dd4fe98b66c735aac3841b|concept
Life Expectancy|4|concept|ec5c38d181dd4fe98b66c735aac3841b|concept
Healthcare Spending|5|concept|ec5c38d181dd4fe98b66c735aac3841b|concept
GDP|3|object|ec5c38d181dd4fe98b66c735aac3841b|concept
Role of Health Finance in G20 Countries|5|concept|67bf46897ef2443ea58021ade0df45a0|concept
Higher % GDP Spending in Healthcare|3|event|67bf46897ef2443ea58021ade0df45a0|concept
Universal Health Care Coverage|4|concept|67bf46897ef2443ea58021ade0df45a0|concept
WHO Data|2|document|67bf46897ef2443ea58021ade0df45a0|concept
Healthcare Spending and Health Outcomes|4|event|67bf46897ef2443ea58021ade0df45a0|concept
Innovative Financing Mechanisms|3|object|67bf46897ef2443ea58021ade0df45a0|concept
G20 Countries|4|organization|67bf46897ef2443ea58021ade0df45a0|concept
Out-of-Pocket Expenses|3|concept|67bf46897ef2443ea58021ade0df45a0|concept
health equity|5|concept|cee9405d7f9345ac9beb4b3fbf485aec|concept
health disparities|4|concept|cee9405d7f9345ac9beb4b3fbf485aec|concept
socioeconomic status|3|concept|cee9405d7f9345ac9beb4b3fbf485aec|concept
race|3|concept|cee9405d7f9345ac9beb4b3fbf485aec|concept
ethnicity|3|concept|cee9405d7f9345ac9beb4b3fbf485aec|concept
gender|3|concept|cee9405d7f9345ac9beb4b3fbf485aec|concept
geographic location|3|concept|cee9405d7f9345ac9beb4b3fbf485aec|concept
access to healthcare services|4|concept|cee9405d7f9345ac9beb4b3fbf485aec|concept
redistributing resources|3|concept|cee9405d7f9345ac9beb4b3fbf485aec|concept
targeted healthcare programs|3|concept|cee9405d7f9345ac9beb4b3fbf485aec|concept
improving access to quality healthcare services|4|concept|cee9405d7f9345ac9beb4b3fbf485aec|concept
addressing social and economic inequalities|3|concept|cee9405d7f9345ac9beb4b3fbf485aec|concept
promoting health education and prevention|3|concept|cee9405d7f9345ac9beb4b3fbf485aec|concept
Universal Health Coverage (UHC)|4|concept|cee9405d7f9345ac9beb4b3fbf485aec|concept
Global|2|organisation|cee9405d7f9345ac9beb4b3fbf485aec|concept
India|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept
Indonesia|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept
Turkiye|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept
China|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept
Singapore|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept
South Korea|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept
Netherlands|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept
UK|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept
Canada|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept
United States|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept
Germany|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept
France|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept
Japan|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept
Spain|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept
Brazil|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept
Argentina|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept
South Africa|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept
Russia|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept
Australia|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept
Mexico|2|place|cee9405d7f9345ac9beb4b3fbf485aec|concept
Accelerating Global Health|5|event|b3125524cd434526969844ef534e60b7|concept
Pathways to Health Equity for the G20|5|concept|b3125524cd434526969844ef534e60b7|concept
COVID-19 pandemic|4|event|b3125524cd434526969844ef534e60b7|concept
G20 countries|5|organisation|b3125524cd434526969844ef534e60b7|concept
Universal Health Coverage (UHC)|4|concept|b3125524cd434526969844ef534e60b7|concept
Out-Of-Pocket Expenses (OOPE)|3|concept|b3125524cd434526969844ef534e60b7|concept
maternal, newborn and child health|3|concept|9cfbef4b83674b20b627a9af06d3ae12|concept
infectious diseases|2|concept|9cfbef4b83674b20b627a9af06d3ae12|concept
non-communicable diseases|3|concept|9cfbef4b83674b20b627a9af06d3ae12|concept
service capacity and access|2|concept|9cfbef4b83674b20b627a9af06d3ae12|concept
general and most disadvantaged populations|3|concept|9cfbef4b83674b20b627a9af06d3ae12|concept
catastrophic OOP healthcare spending|4|concept|9cfbef4b83674b20b627a9af06d3ae12|concept
G20 countries|3|organisation|9cfbef4b83674b20b627a9af06d3ae12|concept
Spain and Singapore|2|place|9cfbef4b83674b20b627a9af06d3ae12|concept
WHO data6UHC|3|document|9cfbef4b83674b20b627a9af06d3ae12|concept
Figure 4|2|object|9cfbef4b83674b20b627a9af06d3ae12|concept
Past Decade for G20 Countries|3|event|9cfbef4b83674b20b627a9af06d3ae12|concept
Lower Out of Pocket Expenditure as a% of Current Health Expenditure|5|concept|8557a7dfb0ce4db8a2b165aedc19d757|concept
Global average|3|misc|8557a7dfb0ce4db8a2b165aedc19d757|concept
2009|1|event|8557a7dfb0ce4db8a2b165aedc19d757|concept
ZAFTURTUR|1|miscellaneous|8557a7dfb0ce4db8a2b165aedc19d757|concept
KSA KSAFRA|1|organisation|8557a7dfb0ce4db8a2b165aedc19d757|concept
FRA|2|country|8557a7dfb0ce4db8a2b165aedc19d757|concept
USAUSAJPN|2|organisation|8557a7dfb0ce4db8a2b165aedc19d757|concept
JPNDEU|1|organisation|8557a7dfb0ce4db8a2b165aedc19d757|concept
AUSSPN|2|country|8557a7dfb0ce4db8a2b165aedc19d757|concept
SPNITA|1|organisation|8557a7dfb0ce4db8a2b165aedc19d757|concept
ITA|2|country|8557a7dfb0ce4db8a2b165aedc19d757|concept
BRABRAKOR|1|miscellaneous|8557a7dfb0ce4db8a2b165aedc19d757|concept
CHI|2|country|8557a7dfb0ce4db8a2b165aedc19d757|concept
CHIRUS|1|miscellaneous|8557a7dfb0ce4db8a2b165aedc19d757|concept
RUSMEX|1|miscellaneous|8557a7dfb0ce4db8a2b165aedc19d757|concept
MEX|2|country|8557a7dfb0ce4db8a2b165aedc19d757|concept
IDN|1|organisation|8557a7dfb0ce4db8a2b165aedc19d757|concept
IDNIND|1|miscellaneous|8557a7dfb0ce4db8a2b165aedc19d757|concept
INDKOR|1|organisation|8557a7dfb0ce4db8a2b165aedc19d757|concept
SGP|2|country|8557a7dfb0ce4db8a2b165aedc19d757|concept
SGPCAN|1|organisation|8557a7dfb0ce4db8a2b165aedc19d757|concept
CAN|2|country|8557a7dfb0ce4db8a2b165aedc19d757|concept
UKUK|2|country|8557a7dfb0ce4db8a2b165aedc19d757|concept
DEU|2|country|8557a7dfb0ce4db8a2b165aedc19d757|concept
ARG ARG|1|organisation|8557a7dfb0ce4db8a2b165aedc19d757|concept
ZAF|2|country|8557a7dfb0ce4db8a2b165aedc19d757|concept
Health Finance|5|concept|2637f57224b34d4895cf7ade5482c61c|concept
G20 Countries|4|event|2637f57224b34d4895cf7ade5482c61c|concept
Universal Health Coverage (UHC)|5|concept|2637f57224b34d4895cf7ade5482c61c|concept
Out-of-Pocket Expenditure (OOPE)|4|concept|2637f57224b34d4895cf7ade5482c61c|concept
Green Highlighted Countries|3|event|2637f57224b34d4895cf7ade5482c61c|concept
Best Practices|4|concept|2637f57224b34d4895cf7ade5482c61c|concept
Indonesia|3|place|2637f57224b34d4895cf7ade5482c61c|concept
JKN National Health Insurance|2|document|2637f57224b34d4895cf7ade5482c61c|concept
JKN program|5|program|f2ee990cbb1942db85479fce8ded4160|concept
Indonesian citizens|4|concept|f2ee990cbb1942db85479fce8ded4160|concept
Social Security Agency for Health (B P J S)|3|organisation|f2ee990cbb1942db85479fce8ded4160|concept
Healthcare providers|2|object|f2ee990cbb1942db85479fce8ded4160|concept
medical benefit package|3|concept|f2ee990cbb1942db85479fce8ded4160|concept
Out-of-pocket expenditure (OOP)|2|condition|f2ee990cbb1942db85479fce8ded4160|concept
Low and medium-income countries (LMICs)|1|concept|f2ee990cbb1942db85479fce8ded4160|concept
Indonesia|5|place|36832b98f50e46df903ea924ff5e55c5|concept
medicines|4|object|36832b98f50e46df903ea924ff5e55c5|concept
healthcare expenditure|3|concept|36832b98f50e46df903ea924ff5e55c5|concept
OOP payments|2|misc|36832b98f50e46df903ea924ff5e55c5|concept
drug pricing and procurement|4|concept|36832b98f50e46df903ea924ff5e55c5|concept
Accelerating Global Health|5|event|86eac922752743339f35699cfccec378|concept
Pathways to Health Equity for the G20|4|concept|86eac922752743339f35699cfccec378|concept
generic medicine pricing policy|5|event|86eac922752743339f35699cfccec378|concept
Maximum Retail Price set by the MOH|3|document|86eac922752743339f35699cfccec378|concept
2010 study|4|event|86eac922752743339f35699cfccec378|concept
public hospitals|3|organisation|86eac922752743339f35699cfccec378|concept
private pharmacies|2|object|86eac922752743339f35699cfccec378|concept
NGO hospitals|3|organisation|86eac922752743339f35699cfccec378|concept
Lowest Price Generic (LPG) medicines|4|object|86eac922752743339f35699cfccec378|concept
Innovator Brand (IB) medicines|4|object|86eac922752743339f35699cfccec378|concept
2010 prices|3|document|86eac922752743339f35699cfccec378|concept
2004 prices|3|document|86eac922752743339f35699cfccec378|concept
declines ranging from 40 percent to 2200 percent|3|misc|86eac922752743339f35699cfccec378|concept
generic medicine pricing policies have succeeded in lowering the price of medicines|4|event|86eac922752743339f35699cfccec378|concept
variation in implementation|3|condition|86eac922752743339f35699cfccec378|concept
excess paid by patients compared to MOH set prices|4|misc|86eac922752743339f35699cfccec378|concept
narrow the differences|3|condition|86eac922752743339f35699cfccec378|concept
more recently|2|misc|86eac922752743339f35699cfccec378|concept
state-owned enterprises|5|organisation|e66fc805e2f748178c0c1270b907aec8|concept
drug procurement|4|event|e66fc805e2f748178c0c1270b907aec8|concept
generic medications|5|object|e66fc805e2f748178c0c1270b907aec8|concept
public awareness campaigns|4|event|e66fc805e2f748178c0c1270b907aec8|concept
financial incentives|3|misc|e66fc805e2f748178c0c1270b907aec8|concept
UHC|5|concept|e663f199a53b4d5094921d1e38169663|concept
BPJS|4|organisation|e663f199a53b4d5094921d1e38169663|concept
national policies|4|concept|e663f199a53b4d5094921d1e38169663|concept
JKN|3|organisation|e663f199a53b4d5094921d1e38169663|concept
healthcare providers|4|object|e663f199a53b4d5094921d1e38169663|concept
public and private hospitals|3|object|e663f199a53b4d5094921d1e38169663|concept
clinics and facilities|3|object|e663f199a53b4d5094921d1e38169663|concept
healthcare infrastructure|4|object|e663f199a53b4d5094921d1e38169663|concept
disparities in healthcare infrastructure|3|condition|e663f199a53b4d5094921d1e38169663|concept
eldercare sector|4|concept|5655410587404d1a8412a9fc74acd655|concept
GDP growth|3|concept|5655410587404d1a8412a9fc74acd655|concept
12,000 and 17,000 beds|3|object|5655410587404d1a8412a9fc74acd655|concept
Singapore government|4|organisation|5655410587404d1a8412a9fc74acd655|concept
healthy economic and GDP growth|3|concept|5655410587404d1a8412a9fc74acd655|concept
institutional places|3|object|5655410587404d1a8412a9fc74acd655|concept
2nd fastest aging economy in Asia|4|concept|5655410587404d1a8412a9fc74acd655|concept
Singaporeans above 65 by 2030|4|condition|5655410587404d1a8412a9fc74acd655|concept
land and building costs of residential nursing homes|3|object|5655410587404d1a8412a9fc74acd655|concept
competitive bids for operators|3|event|5655410587404d1a8412a9fc74acd655|concept
means tested seniors|3|condition|5655410587404d1a8412a9fc74acd655|concept
substantial subsidies of up to 80 percent of monthly fees|3|object|5655410587404d1a8412a9fc74acd655|concept
Widening coverage|4|concept|47a256fcc0844063998f9a4ffb3f1c94|concept
MediShield Life|5|organisation|47a256fcc0844063998f9a4ffb3f1c94|concept
pre-existing conditions|4|condition|47a256fcc0844063998f9a4ffb3f1c94|concept
older individuals|3|misc|47a256fcc0844063998f9a4ffb3f1c94|concept
Accelerating Global Health|4|event|bab2aa6e0ee048878763f123e2e739d0|concept
G20|3|organisation|bab2aa6e0ee048878763f123e2e739d0|concept
hospital bills|4|concept|bab2aa6e0ee048878763f123e2e739d0|concept
large outpatient treatments|3|event|bab2aa6e0ee048878763f123e2e739d0|concept
dialysis|2|object|bab2aa6e0ee048878763f123e2e739d0|concept
chemotherapy|2|object|bab2aa6e0ee048878763f123e2e739d0|concept
CareShield Life|3|concept|bab2aa6e0ee048878763f123e2e739d0|concept
long-term insurance|2|object|bab2aa6e0ee048878763f123e2e739d0|concept
severe disability|3|concept|bab2aa6e0ee048878763f123e2e739d0|concept
cash payouts|2|object|bab2aa6e0ee048878763f123e2e739d0|concept
long-term care costs|3|concept|bab2aa6e0ee048878763f123e2e739d0|concept
nursing home fees|2|object|bab2aa6e0ee048878763f123e2e739d0|concept
MediShield|3|concept|bab2aa6e0ee048878763f123e2e739d0|concept
CareShield premiums|2|object|bab2aa6e0ee048878763f123e2e739d0|concept
Medisave|3|concept|bab2aa6e0ee048878763f123e2e739d0|concept
Ministry of Health|2|organisation|bab2aa6e0ee048878763f123e2e739d0|concept
decision-making and support services|3|concept|bab2aa6e0ee048878763f123e2e739d0|concept
Agency for Care Effectiveness (ACE)|2|organisation|bab2aa6e0ee048878763f123e2e739d0|concept
Pharmacoeconomic and Drug Utilization Unit (PEDU)|4|organisation|325c82ae1f6d45ca8776fccb347158ae|concept
Health Technology Assessment (HTA) unit|3|concept|325c82ae1f6d45ca8776fccb347158ae|concept
Ministry of Health's (MOH) Drug Advisory Committee|3|organisation|325c82ae1f6d45ca8776fccb347158ae|concept
Standardised HTA methods and processes|3|concept|325c82ae1f6d45ca8776fccb347158ae|concept
Advanced Clinical Evidence (ACE)|2|organisation|325c82ae1f6d45ca8776fccb347158ae|concept
Bandwidth limitations and lack of skilled HTA practitioners|3|condition|325c82ae1f6d45ca8776fccb347158ae|concept
Public healthcare clusters|2|organisation|325c82ae1f6d45ca8776fccb347158ae|concept
ALPS Healthcare|2|organisation|325c82ae1f6d45ca8776fccb347158ae|concept
Supply chain partner|2|concept|325c82ae1f6d45ca8776fccb347158ae|concept
Health Finance|5|concept|a4172b8d44d642dd8993e93089d0e52f|concept
G20 Countries|4|organisation|a4172b8d44d642dd8993e93089d0e52f|concept
GP/family physician|3|concept|a4172b8d44d642dd8993e93089d0e52f|concept
hospital-centric healthcare system|3|concept|a4172b8d44d642dd8993e93089d0e52f|concept
preventive model|3|concept|a4172b8d44d642dd8993e93089d0e52f|concept
universal health care|4|concept|a4172b8d44d642dd8993e93089d0e52f|concept
Indonesia|2|place|a4172b8d44d642dd8993e93089d0e52f|concept
Singapore|2|place|a4172b8d44d642dd8993e93089d0e52f|concept
primary care|3|concept|a4172b8d44d642dd8993e93089d0e52f|concept
judicious purchasing and effective procurement|2|misc|a4172b8d44d642dd8993e93089d0e52f|concept
Southeast Asia|4|place|1324e2bb4f5742cab74473e14d467926|concept
ASEAN countries|3|organisation|1324e2bb4f5742cab74473e14d467926|concept
RESYST|2|concept|1324e2bb4f5742cab74473e14d467926|concept
SPARC|2|concept|1324e2bb4f5742cab74473e14d467926|concept
SEARCH|3|organisation|1324e2bb4f5742cab74473e14d467926|concept
National University of Singapore|2|place|1324e2bb4f5742cab74473e14d467926|concept
Telehealth|4|concept|76280917c6254c15b067914f14125841|concept
insurtech|3|concept|76280917c6254c15b067914f14125841|concept
COVID-19 pandemic|2|event|76280917c6254c15b067914f14125841|concept
Singapore|3|place|76280917c6254c15b067914f14125841|concept
Indonesia|4|place|76280917c6254c15b067914f14125841|concept
mobile services|3|concept|76280917c6254c15b067914f14125841|concept
micro-insurance|2|concept|76280917c6254c15b067914f14125841|concept
Accelerating Global Health|5|concept|4dbae5e4a3ee45bdbf9d55dec8921c2c|concept
Pathways to Health Equity for the G20|5|concept|4dbae5e4a3ee45bdbf9d55dec8921c2c|concept
UHC (Universal Health Coverage)|4|concept|4dbae5e4a3ee45bdbf9d55dec8921c2c|concept
G20 countries|4|organisation|4dbae5e4a3ee45bdbf9d55dec8921c2c|concept
National University of Singapore's Saw Swee Hock School of Public Health|3|place|4dbae5e4a3ee45bdbf9d55dec8921c2c|concept
Associate Professor Jeremy Lim|2|person|4dbae5e4a3ee45bdbf9d55dec8921c2c|concept
Janice Tan|1|person|4dbae5e4a3ee45bdbf9d55dec8921c2c|concept
diverse landscapes|3|misc|2f3c4ce941c14624bfbd3da82ff8def7|concept
public and private sector hospitals|4|place|2f3c4ce941c14624bfbd3da82ff8def7|concept
nursing homes|3|place|2f3c4ce941c14624bfbd3da82ff8def7|concept
singapore and malaysia|4|location|2f3c4ce941c14624bfbd3da82ff8def7|concept
